[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fakOGjOubCpkf6R4zyJkmaJQNRliaivX5PnSTjJpyaks":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":84,"rows":91},"Henry Ford Health System",[4],292,false,61,17,125785,38,186,[14,17,20,22,24,26,29,32],{"name":15,"count":16},"Insomnia",12,{"name":18,"count":19},"Pain",7,{"name":21,"count":19},"Coronary Artery Disease",{"name":23,"count":19},"Hidradenitis Suppurativa",{"name":25,"count":19},"Vitiligo",{"name":27,"count":28},"Asthma",6,{"name":30,"count":31},"Ischemic Stroke",4,{"name":33,"count":31},"Healthy",[35,40,45,50,55,59,64,69,74,79],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT03825809","Nonopioid Analgesia After Labral Surgery","2020-01-20","Celecoxib",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04181476","Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects","2021-01-18","Sunscreening Agents",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT04432259","Oral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty","2022-06","Dexamethasone",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT05766683","Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines","2023-06-20","onabotulinumtoxinA at a depth of 2mm",{"nctId":56,"briefTitle":57,"date":58,"intervention":39},"NCT05488847","Opioid-Free Pain Protocol After Shoulder Arthroplasty","2024-12-11",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07037888","Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial","2025-09","Ketorolac",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT04233749","The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans","2025-12-30","Tranexamic acid",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT03718637","Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)","2026-05-17","Smith & Nephew Bioinductive Implant",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT05330221","Project 2: ACHIEVE- HF","2026-06-30","PHARM-PAL2",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT06113211","Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures","2026-09-15","Narcotic pain medication",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,191,226,260,300,327,350,374,392,410,428,446,464,482,500,518,536,554,581,621,651,677,703,721,746,801,826,852,872,898,916,941,963,981,1006,1031,1049,1081,1104,1163,1201,1227,1259,1281,1308,1333,1363,1381,1399,1417,1442,1460,1486,1509,1527,1552,1577,1595,1621,1648,1666,1690,1715,1733,1758,1776,1802,1820,1843,1861,1887,1912,1930,1954,1979,1997,2026,2044,2070,2095,2120,2145,2179,2207,2225,2251,2278,2303,2321,2344,2368,2395,2413,2440,2458,2481,2506,2524,2548,2580,2602,2625,2649,2674,2692,2717,2742,2766,2789,2814,2841,2865,2890,2914,2936,2962,2980,3006,3030,3048,3073,3096,3119,3143,3168,3186,3210,3236,3261,3279,3315,3341,3359,3382],{"intervention":63,"totalTrials":19,"cells":93},{"EARLY_PHASE1":94,"PHASE1":113,"PHASE2":115,"PHASE3":127,"PHASE4":145,"NA":189},{"trials":95,"activeCount":112},[96],{"nctId":97,"briefTitle":98,"status":99,"phases":100,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":104,"interventions":107},"NCT03820193","Nonopioid Analgesia After Arthroscopic Meniscus Surgery","COMPLETED",[85],"2020-06-20","2021-01-20","2019-01-22",[105,106],"Meniscus Disorder","Narcotic Use",[39,108,63,109,110,111],"Hydrocodon\u002FAcetaminophen","Gabapentin","Acetaminophen","Diazepam",0,{"trials":114,"activeCount":112},[],{"trials":116,"activeCount":112},[117],{"nctId":118,"briefTitle":119,"status":99,"phases":120,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":123,"interventions":125},"NCT03818919","Nonopioid Analgesia After Rotator Cuff Repair",[87],"2020-12-31",70,[124],"Rotator Cuff Tear",[39,63,109,110,111,126],"Hydrocodone-Acetaminophen",{"trials":128,"activeCount":144,"soonestReadout":38},[129,136],{"nctId":36,"briefTitle":37,"status":130,"phases":131,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":134,"interventions":135},"RECRUITING",[87,88],"2020-05-20",100,[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":139,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":141,"interventions":143},"NCT03818932","Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction",[87,88],90,[142],"Anterior Cruciate Ligament Injury",[39,126,63,109,110,111],1,{"trials":146,"activeCount":188,"soonestReadout":58},[147,160,178],{"nctId":148,"briefTitle":149,"status":150,"phases":151,"primaryCompletion":152,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":158},"NCT03278691","Ketorolac on Posterior Thoracolumbar Spinal Fusions","UNKNOWN",[89],"2023-12-31","2025-12-31","2017-10-03",600,[157],"Thoracolumbar Spinal Fusions",[159,63],"Saline",{"nctId":56,"briefTitle":57,"status":161,"phases":162,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":169},"ACTIVE_NOT_RECRUITING",[89],"2026-09-01","2022-06-25",83,[167,168],"Shoulder Arthropathy","Shoulder Pain",[39,170,171,49,110,172,173,63,174,175,176,177],"Pregabalin","Tramadol","Ropivicaine","Epinephrine","Tizanidine","Magnesium","Ibuprofen","Oxycodone Hydrochloride 5 Mg",{"nctId":60,"briefTitle":61,"status":130,"phases":179,"primaryCompletion":62,"completion":180,"start":181,"enrollment":133,"conditions":182,"interventions":185},[89],"2026-12","2023-12-13",[183,184],"Femoracetabular Impingement","Hip Arthroscopy",[63,186,186,186,187],"Control","Omeprazole",2,{"trials":190,"activeCount":112},[],{"intervention":39,"totalTrials":192,"cells":193},5,{"EARLY_PHASE1":194,"PHASE1":200,"PHASE2":202,"PHASE3":208,"PHASE4":218,"NA":224},{"trials":195,"activeCount":112},[196],{"nctId":97,"briefTitle":98,"status":99,"phases":197,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":198,"interventions":199},[85],[105,106],[39,108,63,109,110,111],{"trials":201,"activeCount":112},[],{"trials":203,"activeCount":112},[204],{"nctId":118,"briefTitle":119,"status":99,"phases":205,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":206,"interventions":207},[87],[124],[39,63,109,110,111,126],{"trials":209,"activeCount":144,"soonestReadout":38},[210,214],{"nctId":36,"briefTitle":37,"status":130,"phases":211,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":212,"interventions":213},[87,88],[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":215,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":216,"interventions":217},[87,88],[142],[39,126,63,109,110,111],{"trials":219,"activeCount":144,"soonestReadout":58},[220],{"nctId":56,"briefTitle":57,"status":161,"phases":221,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":222,"interventions":223},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":225,"activeCount":112},[],{"intervention":110,"totalTrials":192,"cells":227},{"EARLY_PHASE1":228,"PHASE1":234,"PHASE2":236,"PHASE3":242,"PHASE4":252,"NA":258},{"trials":229,"activeCount":112},[230],{"nctId":97,"briefTitle":98,"status":99,"phases":231,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":232,"interventions":233},[85],[105,106],[39,108,63,109,110,111],{"trials":235,"activeCount":112},[],{"trials":237,"activeCount":112},[238],{"nctId":118,"briefTitle":119,"status":99,"phases":239,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":240,"interventions":241},[87],[124],[39,63,109,110,111,126],{"trials":243,"activeCount":144,"soonestReadout":38},[244,248],{"nctId":36,"briefTitle":37,"status":130,"phases":245,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":246,"interventions":247},[87,88],[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":249,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":250,"interventions":251},[87,88],[142],[39,126,63,109,110,111],{"trials":253,"activeCount":144,"soonestReadout":58},[254],{"nctId":56,"briefTitle":57,"status":161,"phases":255,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":256,"interventions":257},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":259,"activeCount":112},[],{"intervention":49,"totalTrials":261,"cells":262},3,{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":298},{"trials":264,"activeCount":112},[],{"trials":266,"activeCount":112},[],{"trials":268,"activeCount":112},[],{"trials":270,"activeCount":112},[],{"trials":272,"activeCount":188,"soonestReadout":48},[273,283,294],{"nctId":274,"briefTitle":275,"status":276,"phases":277,"primaryCompletion":278,"completion":278,"start":279,"enrollment":112,"conditions":280,"interventions":282},"NCT03877549","Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery","WITHDRAWN",[89],"2022-06-15","2019-05-24",[281],"Post Operative Pain",[49],{"nctId":46,"briefTitle":47,"status":284,"phases":285,"primaryCompletion":48,"completion":286,"start":287,"enrollment":288,"conditions":289,"interventions":293},"NOT_YET_RECRUITING",[89],"2022-12","2020-07",300,[290,291,292],"Arthritis Knee","Postoperative Nausea","Postoperative Pain",[49],{"nctId":56,"briefTitle":57,"status":161,"phases":295,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":296,"interventions":297},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":299,"activeCount":112},[],{"intervention":301,"totalTrials":144,"cells":302},"Bioinductive implant",{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":325},{"trials":304,"activeCount":112},[],{"trials":306,"activeCount":112},[],{"trials":308,"activeCount":112},[],{"trials":310,"activeCount":112},[],{"trials":312,"activeCount":144,"soonestReadout":317},[313],{"nctId":314,"briefTitle":315,"status":130,"phases":316,"primaryCompletion":317,"completion":318,"start":319,"enrollment":320,"conditions":321,"interventions":324},"NCT05439850","Bioinductive Patch for Full-Thickness Rotator Cuff Tears",[89],"2028-07-01","2029-07-01","2022-08-16",78,[322,323],"Rotator Cuff Tears","Rotator Cuff Tear Arthropathy",[301],{"trials":326,"activeCount":112},[],{"intervention":73,"totalTrials":144,"cells":328},{"EARLY_PHASE1":329,"PHASE1":331,"PHASE2":333,"PHASE3":335,"PHASE4":337,"NA":348},{"trials":330,"activeCount":112},[],{"trials":332,"activeCount":112},[],{"trials":334,"activeCount":112},[],{"trials":336,"activeCount":112},[],{"trials":338,"activeCount":144,"soonestReadout":72},[339],{"nctId":70,"briefTitle":71,"status":130,"phases":340,"primaryCompletion":72,"completion":341,"start":342,"enrollment":343,"conditions":344,"interventions":347},[89],"2027-01-17","2019-04-17",40,[345,346],"Tennis Elbow","Lateral Epicondylitis",[73],{"trials":349,"activeCount":112},[],{"intervention":83,"totalTrials":144,"cells":351},{"EARLY_PHASE1":352,"PHASE1":354,"PHASE2":356,"PHASE3":358,"PHASE4":360,"NA":372},{"trials":353,"activeCount":112},[],{"trials":355,"activeCount":112},[],{"trials":357,"activeCount":112},[],{"trials":359,"activeCount":112},[],{"trials":361,"activeCount":144,"soonestReadout":82},[362],{"nctId":80,"briefTitle":81,"status":130,"phases":363,"primaryCompletion":82,"completion":82,"start":364,"enrollment":365,"conditions":366,"interventions":370},[89],"2024-10-01",75,[367,368,369],"Opioid Use","Fractures, Bone","Trauma",[83,371],"Nonnarcotic pain medications",{"trials":373,"activeCount":112},[],{"intervention":371,"totalTrials":144,"cells":375},{"EARLY_PHASE1":376,"PHASE1":378,"PHASE2":380,"PHASE3":382,"PHASE4":384,"NA":390},{"trials":377,"activeCount":112},[],{"trials":379,"activeCount":112},[],{"trials":381,"activeCount":112},[],{"trials":383,"activeCount":112},[],{"trials":385,"activeCount":144,"soonestReadout":82},[386],{"nctId":80,"briefTitle":81,"status":130,"phases":387,"primaryCompletion":82,"completion":82,"start":364,"enrollment":365,"conditions":388,"interventions":389},[89],[367,368,369],[83,371],{"trials":391,"activeCount":112},[],{"intervention":170,"totalTrials":144,"cells":393},{"EARLY_PHASE1":394,"PHASE1":396,"PHASE2":398,"PHASE3":400,"PHASE4":402,"NA":408},{"trials":395,"activeCount":112},[],{"trials":397,"activeCount":112},[],{"trials":399,"activeCount":112},[],{"trials":401,"activeCount":112},[],{"trials":403,"activeCount":144,"soonestReadout":58},[404],{"nctId":56,"briefTitle":57,"status":161,"phases":405,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":406,"interventions":407},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":409,"activeCount":112},[],{"intervention":171,"totalTrials":144,"cells":411},{"EARLY_PHASE1":412,"PHASE1":414,"PHASE2":416,"PHASE3":418,"PHASE4":420,"NA":426},{"trials":413,"activeCount":112},[],{"trials":415,"activeCount":112},[],{"trials":417,"activeCount":112},[],{"trials":419,"activeCount":112},[],{"trials":421,"activeCount":144,"soonestReadout":58},[422],{"nctId":56,"briefTitle":57,"status":161,"phases":423,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":424,"interventions":425},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":427,"activeCount":112},[],{"intervention":172,"totalTrials":144,"cells":429},{"EARLY_PHASE1":430,"PHASE1":432,"PHASE2":434,"PHASE3":436,"PHASE4":438,"NA":444},{"trials":431,"activeCount":112},[],{"trials":433,"activeCount":112},[],{"trials":435,"activeCount":112},[],{"trials":437,"activeCount":112},[],{"trials":439,"activeCount":144,"soonestReadout":58},[440],{"nctId":56,"briefTitle":57,"status":161,"phases":441,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":442,"interventions":443},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":445,"activeCount":112},[],{"intervention":173,"totalTrials":144,"cells":447},{"EARLY_PHASE1":448,"PHASE1":450,"PHASE2":452,"PHASE3":454,"PHASE4":456,"NA":462},{"trials":449,"activeCount":112},[],{"trials":451,"activeCount":112},[],{"trials":453,"activeCount":112},[],{"trials":455,"activeCount":112},[],{"trials":457,"activeCount":144,"soonestReadout":58},[458],{"nctId":56,"briefTitle":57,"status":161,"phases":459,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":460,"interventions":461},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":463,"activeCount":112},[],{"intervention":174,"totalTrials":144,"cells":465},{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":474,"NA":480},{"trials":467,"activeCount":112},[],{"trials":469,"activeCount":112},[],{"trials":471,"activeCount":112},[],{"trials":473,"activeCount":112},[],{"trials":475,"activeCount":144,"soonestReadout":58},[476],{"nctId":56,"briefTitle":57,"status":161,"phases":477,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":478,"interventions":479},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":481,"activeCount":112},[],{"intervention":175,"totalTrials":144,"cells":483},{"EARLY_PHASE1":484,"PHASE1":486,"PHASE2":488,"PHASE3":490,"PHASE4":492,"NA":498},{"trials":485,"activeCount":112},[],{"trials":487,"activeCount":112},[],{"trials":489,"activeCount":112},[],{"trials":491,"activeCount":112},[],{"trials":493,"activeCount":144,"soonestReadout":58},[494],{"nctId":56,"briefTitle":57,"status":161,"phases":495,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":496,"interventions":497},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":499,"activeCount":112},[],{"intervention":177,"totalTrials":144,"cells":501},{"EARLY_PHASE1":502,"PHASE1":504,"PHASE2":506,"PHASE3":508,"PHASE4":510,"NA":516},{"trials":503,"activeCount":112},[],{"trials":505,"activeCount":112},[],{"trials":507,"activeCount":112},[],{"trials":509,"activeCount":112},[],{"trials":511,"activeCount":144,"soonestReadout":58},[512],{"nctId":56,"briefTitle":57,"status":161,"phases":513,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":514,"interventions":515},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":517,"activeCount":112},[],{"intervention":186,"totalTrials":144,"cells":519},{"EARLY_PHASE1":520,"PHASE1":522,"PHASE2":524,"PHASE3":526,"PHASE4":528,"NA":534},{"trials":521,"activeCount":112},[],{"trials":523,"activeCount":112},[],{"trials":525,"activeCount":112},[],{"trials":527,"activeCount":112},[],{"trials":529,"activeCount":144,"soonestReadout":62},[530],{"nctId":60,"briefTitle":61,"status":130,"phases":531,"primaryCompletion":62,"completion":180,"start":181,"enrollment":133,"conditions":532,"interventions":533},[89],[183,184],[63,186,186,186,187],{"trials":535,"activeCount":112},[],{"intervention":187,"totalTrials":144,"cells":537},{"EARLY_PHASE1":538,"PHASE1":540,"PHASE2":542,"PHASE3":544,"PHASE4":546,"NA":552},{"trials":539,"activeCount":112},[],{"trials":541,"activeCount":112},[],{"trials":543,"activeCount":112},[],{"trials":545,"activeCount":112},[],{"trials":547,"activeCount":144,"soonestReadout":62},[548],{"nctId":60,"briefTitle":61,"status":130,"phases":549,"primaryCompletion":62,"completion":180,"start":181,"enrollment":133,"conditions":550,"interventions":551},[89],[183,184],[63,186,186,186,187],{"trials":553,"activeCount":112},[],{"intervention":176,"totalTrials":188,"cells":555},{"EARLY_PHASE1":556,"PHASE1":558,"PHASE2":560,"PHASE3":562,"PHASE4":564,"NA":570},{"trials":557,"activeCount":112},[],{"trials":559,"activeCount":112},[],{"trials":561,"activeCount":112},[],{"trials":563,"activeCount":112},[],{"trials":565,"activeCount":144,"soonestReadout":58},[566],{"nctId":56,"briefTitle":57,"status":161,"phases":567,"primaryCompletion":58,"completion":163,"start":164,"enrollment":165,"conditions":568,"interventions":569},[89],[167,168],[39,170,171,49,110,172,173,63,174,175,176,177],{"trials":571,"activeCount":112},[572],{"nctId":573,"briefTitle":574,"status":575,"phases":576,"primaryCompletion":577,"completion":577,"start":578,"enrollment":261,"conditions":579,"interventions":580},"NCT05256147","Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters","TERMINATED",[90],"2016-05-24","2015-08",[25],[176],{"intervention":109,"totalTrials":192,"cells":582},{"EARLY_PHASE1":583,"PHASE1":589,"PHASE2":591,"PHASE3":597,"PHASE4":617,"NA":619},{"trials":584,"activeCount":112},[585],{"nctId":97,"briefTitle":98,"status":99,"phases":586,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":587,"interventions":588},[85],[105,106],[39,108,63,109,110,111],{"trials":590,"activeCount":112},[],{"trials":592,"activeCount":112},[593],{"nctId":118,"briefTitle":119,"status":99,"phases":594,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":595,"interventions":596},[87],[124],[39,63,109,110,111,126],{"trials":598,"activeCount":144,"soonestReadout":38},[599,603,607],{"nctId":36,"briefTitle":37,"status":130,"phases":600,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":601,"interventions":602},[87,88],[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":604,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":605,"interventions":606},[87,88],[142],[39,126,63,109,110,111],{"nctId":608,"briefTitle":609,"status":99,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":614,"interventions":616},"NCT03269344","Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer",[88],"2020-12-09","2017-06-05",65,[615],"Oropharynx Cancer",[109],{"trials":618,"activeCount":112},[],{"trials":620,"activeCount":112},[],{"intervention":111,"totalTrials":31,"cells":622},{"EARLY_PHASE1":623,"PHASE1":629,"PHASE2":631,"PHASE3":637,"PHASE4":647,"NA":649},{"trials":624,"activeCount":112},[625],{"nctId":97,"briefTitle":98,"status":99,"phases":626,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":627,"interventions":628},[85],[105,106],[39,108,63,109,110,111],{"trials":630,"activeCount":112},[],{"trials":632,"activeCount":112},[633],{"nctId":118,"briefTitle":119,"status":99,"phases":634,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":635,"interventions":636},[87],[124],[39,63,109,110,111,126],{"trials":638,"activeCount":144,"soonestReadout":38},[639,643],{"nctId":36,"briefTitle":37,"status":130,"phases":640,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":641,"interventions":642},[87,88],[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":644,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":645,"interventions":646},[87,88],[142],[39,126,63,109,110,111],{"trials":648,"activeCount":112},[],{"trials":650,"activeCount":112},[],{"intervention":126,"totalTrials":261,"cells":652},{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":663,"PHASE4":673,"NA":675},{"trials":654,"activeCount":112},[],{"trials":656,"activeCount":112},[],{"trials":658,"activeCount":112},[659],{"nctId":118,"briefTitle":119,"status":99,"phases":660,"primaryCompletion":121,"completion":121,"start":103,"enrollment":122,"conditions":661,"interventions":662},[87],[124],[39,63,109,110,111,126],{"trials":664,"activeCount":144,"soonestReadout":38},[665,669],{"nctId":36,"briefTitle":37,"status":130,"phases":666,"primaryCompletion":38,"completion":132,"start":103,"enrollment":133,"conditions":667,"interventions":668},[87,88],[106],[39,126,63,109,110,111],{"nctId":137,"briefTitle":138,"status":99,"phases":670,"primaryCompletion":38,"completion":132,"start":103,"enrollment":140,"conditions":671,"interventions":672},[87,88],[142],[39,126,63,109,110,111],{"trials":674,"activeCount":112},[],{"trials":676,"activeCount":112},[],{"intervention":678,"totalTrials":144,"cells":679},"Botulinum Toxin",{"EARLY_PHASE1":680,"PHASE1":682,"PHASE2":684,"PHASE3":686,"PHASE4":699,"NA":701},{"trials":681,"activeCount":112},[],{"trials":683,"activeCount":112},[],{"trials":685,"activeCount":112},[],{"trials":687,"activeCount":144,"soonestReadout":692},[688],{"nctId":689,"briefTitle":690,"status":161,"phases":691,"primaryCompletion":692,"completion":692,"start":693,"enrollment":16,"conditions":694,"interventions":697},"NCT05478551","Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization",[87,88],"2026-12-30","2022-06-01",[695,696],"Scar","Hypertrophic Scar",[678,698],"Normal saline",{"trials":700,"activeCount":112},[],{"trials":702,"activeCount":112},[],{"intervention":698,"totalTrials":144,"cells":704},{"EARLY_PHASE1":705,"PHASE1":707,"PHASE2":709,"PHASE3":711,"PHASE4":717,"NA":719},{"trials":706,"activeCount":112},[],{"trials":708,"activeCount":112},[],{"trials":710,"activeCount":112},[],{"trials":712,"activeCount":144,"soonestReadout":692},[713],{"nctId":689,"briefTitle":690,"status":161,"phases":714,"primaryCompletion":692,"completion":692,"start":693,"enrollment":16,"conditions":715,"interventions":716},[87,88],[695,696],[678,698],{"trials":718,"activeCount":112},[],{"trials":720,"activeCount":112},[],{"intervention":722,"totalTrials":144,"cells":723},"Budesonide",{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":730,"PHASE4":742,"NA":744},{"trials":725,"activeCount":112},[],{"trials":727,"activeCount":112},[],{"trials":729,"activeCount":112},[],{"trials":731,"activeCount":144,"soonestReadout":736},[732],{"nctId":733,"briefTitle":734,"status":130,"phases":735,"primaryCompletion":736,"completion":736,"start":737,"enrollment":738,"conditions":739,"interventions":741},"NCT05509933","Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation",[88],"2027-12-30","2022-11-09",110,[740],"Engraftment Syndrome",[722],{"trials":743,"activeCount":112},[],{"trials":745,"activeCount":112},[],{"intervention":68,"totalTrials":31,"cells":747},{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":763,"PHASE3":784,"PHASE4":786,"NA":799},{"trials":749,"activeCount":112},[],{"trials":751,"activeCount":112},[752],{"nctId":753,"briefTitle":754,"status":99,"phases":755,"primaryCompletion":756,"completion":756,"start":757,"enrollment":758,"conditions":759,"interventions":762},"NCT01683955","Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty",[86],"2013-11-03","2013-01-01",139,[760,761],"Acute Blood Loss Anemia","Osteoarthritis, Hip",[68],{"trials":764,"activeCount":144,"soonestReadout":67},[765,773],{"nctId":65,"briefTitle":66,"status":130,"phases":766,"primaryCompletion":67,"completion":67,"start":767,"enrollment":192,"conditions":768,"interventions":772},[87],"2020-03-17",[769,770,771],"Lichen Planus Pigmentosus","Erythema Dyschromicum Perstans","Ashy Dermatosis of Ramirez",[68],{"nctId":774,"briefTitle":775,"status":99,"phases":776,"primaryCompletion":777,"completion":777,"start":778,"enrollment":779,"conditions":780,"interventions":782},"NCT01370460","Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty",[87],"2012-09","2011-06",101,[760,781],"Osteoarthritis, Knee",[783],"Tranexamic Acid",{"trials":785,"activeCount":112},[],{"trials":787,"activeCount":112},[788],{"nctId":789,"briefTitle":790,"status":99,"phases":791,"primaryCompletion":792,"completion":793,"start":794,"enrollment":165,"conditions":795,"interventions":798},"NCT03037515","Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery",[89],"2018-06-15","2018-07-16","2017-02-15",[796,797],"Blood Loss, Surgical","Blood Loss Anemia",[783],{"trials":800,"activeCount":112},[],{"intervention":802,"totalTrials":144,"cells":803},"Bortezomib",{"EARLY_PHASE1":804,"PHASE1":806,"PHASE2":808,"PHASE3":820,"PHASE4":822,"NA":824},{"trials":805,"activeCount":112},[],{"trials":807,"activeCount":112},[],{"trials":809,"activeCount":144,"soonestReadout":814},[810],{"nctId":811,"briefTitle":812,"status":130,"phases":813,"primaryCompletion":814,"completion":814,"start":815,"enrollment":816,"conditions":817,"interventions":819},"NCT03850366","HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib",[87],"2028-01-01","2016-03-08",15,[818],"Hematological Malignancy",[802],{"trials":821,"activeCount":112},[],{"trials":823,"activeCount":112},[],{"trials":825,"activeCount":112},[],{"intervention":827,"totalTrials":144,"cells":828},"5-Aminolevulinic acid Hydrochloride",{"EARLY_PHASE1":829,"PHASE1":831,"PHASE2":833,"PHASE3":846,"PHASE4":848,"NA":850},{"trials":830,"activeCount":112},[],{"trials":832,"activeCount":112},[],{"trials":834,"activeCount":144,"soonestReadout":839},[835],{"nctId":836,"briefTitle":837,"status":130,"phases":838,"primaryCompletion":839,"completion":840,"start":841,"enrollment":842,"conditions":843,"interventions":845},"NCT06948552","Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA",[87],"2027-12","2028-01","2026-04",10,[844],"Upper Tract Urothelial Carcinoma",[827],{"trials":847,"activeCount":112},[],{"trials":849,"activeCount":112},[],{"trials":851,"activeCount":112},[],{"intervention":44,"totalTrials":144,"cells":853},{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":866,"PHASE4":868,"NA":870},{"trials":855,"activeCount":112},[],{"trials":857,"activeCount":112},[],{"trials":859,"activeCount":144,"soonestReadout":43},[860],{"nctId":41,"briefTitle":42,"status":161,"phases":861,"primaryCompletion":43,"completion":48,"start":862,"enrollment":16,"conditions":863,"interventions":865},[87],"2019-11-05",[864],"Sun Damaged Skin",[44],{"trials":867,"activeCount":112},[],{"trials":869,"activeCount":112},[],{"trials":871,"activeCount":112},[],{"intervention":873,"totalTrials":144,"cells":874},"Cemiplimab",{"EARLY_PHASE1":875,"PHASE1":877,"PHASE2":879,"PHASE3":892,"PHASE4":894,"NA":896},{"trials":876,"activeCount":112},[],{"trials":878,"activeCount":112},[],{"trials":880,"activeCount":144,"soonestReadout":885},[881],{"nctId":882,"briefTitle":883,"status":284,"phases":884,"primaryCompletion":885,"completion":885,"start":886,"enrollment":887,"conditions":888,"interventions":890},"NCT07450183","Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1",[87],"2027-12-01","2026-06-01",33,[889],"Lung Cancer (NSCLC)",[873,891],"Adjuvant chemotherapy",{"trials":893,"activeCount":112},[],{"trials":895,"activeCount":112},[],{"trials":897,"activeCount":112},[],{"intervention":891,"totalTrials":144,"cells":899},{"EARLY_PHASE1":900,"PHASE1":902,"PHASE2":904,"PHASE3":910,"PHASE4":912,"NA":914},{"trials":901,"activeCount":112},[],{"trials":903,"activeCount":112},[],{"trials":905,"activeCount":144,"soonestReadout":885},[906],{"nctId":882,"briefTitle":883,"status":284,"phases":907,"primaryCompletion":885,"completion":885,"start":886,"enrollment":887,"conditions":908,"interventions":909},[87],[889],[873,891],{"trials":911,"activeCount":112},[],{"trials":913,"activeCount":112},[],{"trials":915,"activeCount":112},[],{"intervention":917,"totalTrials":144,"cells":918},"azacitidine",{"EARLY_PHASE1":919,"PHASE1":921,"PHASE2":923,"PHASE3":935,"PHASE4":937,"NA":939},{"trials":920,"activeCount":112},[],{"trials":922,"activeCount":112},[],{"trials":924,"activeCount":144,"soonestReadout":929},[925],{"nctId":926,"briefTitle":927,"status":130,"phases":928,"primaryCompletion":929,"completion":929,"start":930,"enrollment":931,"conditions":932,"interventions":934},"NCT03850418","Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant",[87],"2028-02-20","2019-07-01",43,[933],"Myeloid Malignancy",[917],{"trials":936,"activeCount":112},[],{"trials":938,"activeCount":112},[],{"trials":940,"activeCount":112},[],{"intervention":54,"totalTrials":144,"cells":942},{"EARLY_PHASE1":943,"PHASE1":945,"PHASE2":955,"PHASE3":957,"PHASE4":959,"NA":961},{"trials":944,"activeCount":112},[],{"trials":946,"activeCount":144,"soonestReadout":53},[947],{"nctId":51,"briefTitle":52,"status":161,"phases":948,"primaryCompletion":53,"completion":180,"start":949,"enrollment":950,"conditions":951,"interventions":953},[86],"2023-03-14",20,[952],"Glabellar Frown Lines",[54,954],"onabotulinumtoxinA at a depth of 4mm",{"trials":956,"activeCount":112},[],{"trials":958,"activeCount":112},[],{"trials":960,"activeCount":112},[],{"trials":962,"activeCount":112},[],{"intervention":954,"totalTrials":144,"cells":964},{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":973,"PHASE3":975,"PHASE4":977,"NA":979},{"trials":966,"activeCount":112},[],{"trials":968,"activeCount":144,"soonestReadout":53},[969],{"nctId":51,"briefTitle":52,"status":161,"phases":970,"primaryCompletion":53,"completion":180,"start":949,"enrollment":950,"conditions":971,"interventions":972},[86],[952],[54,954],{"trials":974,"activeCount":112},[],{"trials":976,"activeCount":112},[],{"trials":978,"activeCount":112},[],{"trials":980,"activeCount":112},[],{"intervention":982,"totalTrials":144,"cells":983},"uhCG\u002FEGF",{"EARLY_PHASE1":984,"PHASE1":986,"PHASE2":998,"PHASE3":1000,"PHASE4":1002,"NA":1004},{"trials":985,"activeCount":112},[],{"trials":987,"activeCount":144,"soonestReadout":992},[988],{"nctId":989,"briefTitle":990,"status":130,"phases":991,"primaryCompletion":992,"completion":992,"start":993,"enrollment":994,"conditions":995,"interventions":997},"NCT04886726","PTCY Plus uhCG\u002FEGF for Graft Versus Host Disease Prophylaxis",[86],"2028-11-30","2021-12-23",18,[996],"Graft Versus Host Disease",[982],{"trials":999,"activeCount":112},[],{"trials":1001,"activeCount":112},[],{"trials":1003,"activeCount":112},[],{"trials":1005,"activeCount":112},[],{"intervention":1007,"totalTrials":144,"cells":1008},"Capecitabine",{"EARLY_PHASE1":1009,"PHASE1":1011,"PHASE2":1023,"PHASE3":1025,"PHASE4":1027,"NA":1029},{"trials":1010,"activeCount":112},[],{"trials":1012,"activeCount":144,"soonestReadout":180},[1013],{"nctId":1014,"briefTitle":1015,"status":130,"phases":1016,"primaryCompletion":180,"completion":1017,"start":1018,"enrollment":950,"conditions":1019,"interventions":1021},"NCT06065371","Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy",[86],"2027-05","2024-11-20",[1020],"Gastrointestinal Cancer",[1007,1022],"Sacituzumab govetican",{"trials":1024,"activeCount":112},[],{"trials":1026,"activeCount":112},[],{"trials":1028,"activeCount":112},[],{"trials":1030,"activeCount":112},[],{"intervention":1022,"totalTrials":144,"cells":1032},{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1041,"PHASE3":1043,"PHASE4":1045,"NA":1047},{"trials":1034,"activeCount":112},[],{"trials":1036,"activeCount":144,"soonestReadout":180},[1037],{"nctId":1014,"briefTitle":1015,"status":130,"phases":1038,"primaryCompletion":180,"completion":1017,"start":1018,"enrollment":950,"conditions":1039,"interventions":1040},[86],[1020],[1007,1022],{"trials":1042,"activeCount":112},[],{"trials":1044,"activeCount":112},[],{"trials":1046,"activeCount":112},[],{"trials":1048,"activeCount":112},[],{"intervention":1050,"totalTrials":144,"cells":1051},"Ad5-yCD\u002FmutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery",{"EARLY_PHASE1":1052,"PHASE1":1054,"PHASE2":1073,"PHASE3":1075,"PHASE4":1077,"NA":1079},{"trials":1053,"activeCount":112},[],{"trials":1055,"activeCount":144,"soonestReadout":1060},[1056],{"nctId":1057,"briefTitle":1058,"status":130,"phases":1059,"primaryCompletion":1060,"completion":839,"start":1061,"enrollment":994,"conditions":1062,"interventions":1072},"NCT05686798","Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.",[86],"2027-01","2022-11-29",[1063,1064,1065,1066,1067,1068,1069,1070,1071],"Malignant Glioma of Brain","Astrocytoma","Malignant Astrocytoma","Brain Tumor","Glioma","Brain Cancer","Glioblastoma","Glioblastoma Multiforme","GBM",[1050],{"trials":1074,"activeCount":112},[],{"trials":1076,"activeCount":112},[],{"trials":1078,"activeCount":112},[],{"trials":1080,"activeCount":112},[],{"intervention":78,"totalTrials":144,"cells":1082},{"EARLY_PHASE1":1083,"PHASE1":1085,"PHASE2":1087,"PHASE3":1089,"PHASE4":1091,"NA":1093},{"trials":1084,"activeCount":112},[],{"trials":1086,"activeCount":112},[],{"trials":1088,"activeCount":112},[],{"trials":1090,"activeCount":112},[],{"trials":1092,"activeCount":112},[],{"trials":1094,"activeCount":144,"soonestReadout":77},[1095],{"nctId":75,"briefTitle":76,"status":130,"phases":1096,"primaryCompletion":77,"completion":1097,"start":1098,"enrollment":1099,"conditions":1100,"interventions":1103},[90],"2027-06-30","2023-01-18",364,[1101,1102],"Heart Failure","Hypertension",[78],{"intervention":1105,"totalTrials":31,"cells":1106},"Bupivacaine",{"EARLY_PHASE1":1107,"PHASE1":1119,"PHASE2":1121,"PHASE3":1123,"PHASE4":1125,"NA":1161},{"trials":1108,"activeCount":112},[1109],{"nctId":1110,"briefTitle":1111,"status":99,"phases":1112,"primaryCompletion":1113,"completion":1113,"start":1114,"enrollment":1115,"conditions":1116,"interventions":1117},"NCT02740192","Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?",[85],"2016-12","2016-04",128,[18],[1118,1105],"Ropivacaine",{"trials":1120,"activeCount":112},[],{"trials":1122,"activeCount":112},[],{"trials":1124,"activeCount":112},[],{"trials":1126,"activeCount":112},[1127,1137,1147],{"nctId":1128,"briefTitle":1129,"status":99,"phases":1130,"primaryCompletion":1131,"completion":1131,"start":1132,"enrollment":1133,"conditions":1134,"interventions":1136},"NCT03375112","Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty",[89],"2019-10-01","2017-07-31",122,[1135],"Arthritis of Hip",[1105],{"nctId":1138,"briefTitle":1139,"status":99,"phases":1140,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":140,"conditions":1143,"interventions":1145},"NCT03250507","Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy",[89],"2019-01-30","2017-03-13",[1144],"Hysterectomy",[1105,1146,159],"Liposomal bupivacaine",{"nctId":1148,"briefTitle":1149,"status":99,"phases":1150,"primaryCompletion":1151,"completion":1151,"start":1113,"enrollment":1152,"conditions":1153,"interventions":1159},"NCT02980926","Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty",[89],"2017-03",32,[1154,1155,1156,1157,1158],"Anesthesia, Spinal","Arthroplasty, Replacement, Knee","Pain Management","Early Ambulation","Ambulatory Surgical Procedures",[1160,1105],"Mepivacaine",{"trials":1162,"activeCount":112},[],{"intervention":1118,"totalTrials":261,"cells":1164},{"EARLY_PHASE1":1165,"PHASE1":1171,"PHASE2":1173,"PHASE3":1175,"PHASE4":1177,"NA":1199},{"trials":1166,"activeCount":112},[1167],{"nctId":1110,"briefTitle":1111,"status":99,"phases":1168,"primaryCompletion":1113,"completion":1113,"start":1114,"enrollment":1115,"conditions":1169,"interventions":1170},[85],[18],[1118,1105],{"trials":1172,"activeCount":112},[],{"trials":1174,"activeCount":112},[],{"trials":1176,"activeCount":112},[],{"trials":1178,"activeCount":112},[1179,1189],{"nctId":1180,"briefTitle":1181,"status":99,"phases":1182,"primaryCompletion":1183,"completion":1184,"start":1185,"enrollment":1186,"conditions":1187,"interventions":1188},"NCT02570022","Liposomal Bupivacaine in Total Shoulder Arthroplasty",[89],"2016-05","2016-06","2014-10",57,[18],[1146,1118],{"nctId":1190,"briefTitle":1191,"status":99,"phases":1192,"primaryCompletion":1193,"completion":1194,"start":1195,"enrollment":1196,"conditions":1197,"interventions":1198},"NCT02606448","Exparel Infiltration in Anterior Cruciate Ligament Reconstruction",[89],"2015-09","2015-11","2014-08",84,[18],[1146,1118],{"trials":1200,"activeCount":112},[],{"intervention":1146,"totalTrials":261,"cells":1202},{"EARLY_PHASE1":1203,"PHASE1":1205,"PHASE2":1207,"PHASE3":1209,"PHASE4":1211,"NA":1225},{"trials":1204,"activeCount":112},[],{"trials":1206,"activeCount":112},[],{"trials":1208,"activeCount":112},[],{"trials":1210,"activeCount":112},[],{"trials":1212,"activeCount":112},[1213,1217,1221],{"nctId":1180,"briefTitle":1181,"status":99,"phases":1214,"primaryCompletion":1183,"completion":1184,"start":1185,"enrollment":1186,"conditions":1215,"interventions":1216},[89],[18],[1146,1118],{"nctId":1190,"briefTitle":1191,"status":99,"phases":1218,"primaryCompletion":1193,"completion":1194,"start":1195,"enrollment":1196,"conditions":1219,"interventions":1220},[89],[18],[1146,1118],{"nctId":1138,"briefTitle":1139,"status":99,"phases":1222,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":140,"conditions":1223,"interventions":1224},[89],[1144],[1105,1146,159],{"trials":1226,"activeCount":112},[],{"intervention":1228,"totalTrials":188,"cells":1229},"Biodesign Otologic graft",{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1238,"NA":1257},{"trials":1231,"activeCount":112},[],{"trials":1233,"activeCount":112},[],{"trials":1235,"activeCount":112},[],{"trials":1237,"activeCount":112},[],{"trials":1239,"activeCount":112},[1240,1249],{"nctId":1241,"briefTitle":1242,"status":276,"phases":1243,"primaryCompletion":1244,"completion":1244,"start":1245,"enrollment":112,"conditions":1246,"interventions":1248},"NCT03902938","Use of Biodesign® Otologic Graft in Canal Wall Down Mastoidectomy: A Prospective, Randomized Trial",[89],"2022-07-01","2018-10-02",[1247],"Otologic Disease",[1228],{"nctId":1250,"briefTitle":1251,"status":276,"phases":1252,"primaryCompletion":1244,"completion":1244,"start":1253,"enrollment":112,"conditions":1254,"interventions":1256},"NCT03904316","Use of Biodesign® Otologic Graft in Tympanoplasty",[89],"2018-10-03",[1255],"Tympanic Membrane Perforation",[1228],{"trials":1258,"activeCount":112},[],{"intervention":159,"totalTrials":188,"cells":1260},{"EARLY_PHASE1":1261,"PHASE1":1263,"PHASE2":1265,"PHASE3":1267,"PHASE4":1269,"NA":1279},{"trials":1262,"activeCount":112},[],{"trials":1264,"activeCount":112},[],{"trials":1266,"activeCount":112},[],{"trials":1268,"activeCount":112},[],{"trials":1270,"activeCount":112},[1271,1275],{"nctId":148,"briefTitle":149,"status":150,"phases":1272,"primaryCompletion":152,"completion":153,"start":154,"enrollment":155,"conditions":1273,"interventions":1274},[89],[157],[159,63],{"nctId":1138,"briefTitle":1139,"status":99,"phases":1276,"primaryCompletion":1141,"completion":1141,"start":1142,"enrollment":140,"conditions":1277,"interventions":1278},[89],[1144],[1105,1146,159],{"trials":1280,"activeCount":112},[],{"intervention":1282,"totalTrials":144,"cells":1283},"Methadone",{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1290,"PHASE4":1292,"NA":1306},{"trials":1285,"activeCount":112},[],{"trials":1287,"activeCount":112},[],{"trials":1289,"activeCount":112},[],{"trials":1291,"activeCount":112},[],{"trials":1293,"activeCount":112},[1294],{"nctId":1295,"briefTitle":1296,"status":575,"phases":1297,"primaryCompletion":1298,"completion":1298,"start":1299,"enrollment":1300,"conditions":1301,"interventions":1305},"NCT02025855","Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit",[89],"2017-10","2014-01",9,[1302,1303,1304],"Opioid Use, Unspecified With Withdrawal","Opioid-Induced Disorders","Delirium",[1282],{"trials":1307,"activeCount":112},[],{"intervention":1309,"totalTrials":144,"cells":1310},"emtricitabine\u002Ftenofovir disoproxil fumarate",{"EARLY_PHASE1":1311,"PHASE1":1313,"PHASE2":1315,"PHASE3":1317,"PHASE4":1319,"NA":1331},{"trials":1312,"activeCount":112},[],{"trials":1314,"activeCount":112},[],{"trials":1316,"activeCount":112},[],{"trials":1318,"activeCount":112},[],{"trials":1320,"activeCount":112},[1321],{"nctId":1322,"briefTitle":1323,"status":99,"phases":1324,"primaryCompletion":1325,"completion":1325,"start":1326,"enrollment":1327,"conditions":1328,"interventions":1330},"NCT01234116","Post-Exposure Prophylaxis in Health Care Workers",[89],"2013-05","2011-02",16,[1329],"Human Immunodeficiency Virus",[1309],{"trials":1332,"activeCount":112},[],{"intervention":1334,"totalTrials":144,"cells":1335},"Vancomycin",{"EARLY_PHASE1":1336,"PHASE1":1338,"PHASE2":1340,"PHASE3":1342,"PHASE4":1344,"NA":1361},{"trials":1337,"activeCount":112},[],{"trials":1339,"activeCount":112},[],{"trials":1341,"activeCount":112},[],{"trials":1343,"activeCount":112},[],{"trials":1345,"activeCount":112},[1346],{"nctId":1347,"briefTitle":1348,"status":575,"phases":1349,"primaryCompletion":777,"completion":777,"start":1350,"enrollment":133,"conditions":1351,"interventions":1357},"NCT01734694","Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients",[89],"2011-10",[1352,1353,1354,1355,1356],"Health Care Associated Pneumonia","Osteomyelitis\u002FSeptic Arthritis","Endocarditis","Bacteremia","Acute Bacterial Skin and Skin Structure Infections",[1334,1358,1359,1360],"Ceftaroline","Daptomycin","Linezolid",{"trials":1362,"activeCount":112},[],{"intervention":1358,"totalTrials":144,"cells":1364},{"EARLY_PHASE1":1365,"PHASE1":1367,"PHASE2":1369,"PHASE3":1371,"PHASE4":1373,"NA":1379},{"trials":1366,"activeCount":112},[],{"trials":1368,"activeCount":112},[],{"trials":1370,"activeCount":112},[],{"trials":1372,"activeCount":112},[],{"trials":1374,"activeCount":112},[1375],{"nctId":1347,"briefTitle":1348,"status":575,"phases":1376,"primaryCompletion":777,"completion":777,"start":1350,"enrollment":133,"conditions":1377,"interventions":1378},[89],[1352,1353,1354,1355,1356],[1334,1358,1359,1360],{"trials":1380,"activeCount":112},[],{"intervention":1359,"totalTrials":144,"cells":1382},{"EARLY_PHASE1":1383,"PHASE1":1385,"PHASE2":1387,"PHASE3":1389,"PHASE4":1391,"NA":1397},{"trials":1384,"activeCount":112},[],{"trials":1386,"activeCount":112},[],{"trials":1388,"activeCount":112},[],{"trials":1390,"activeCount":112},[],{"trials":1392,"activeCount":112},[1393],{"nctId":1347,"briefTitle":1348,"status":575,"phases":1394,"primaryCompletion":777,"completion":777,"start":1350,"enrollment":133,"conditions":1395,"interventions":1396},[89],[1352,1353,1354,1355,1356],[1334,1358,1359,1360],{"trials":1398,"activeCount":112},[],{"intervention":1360,"totalTrials":144,"cells":1400},{"EARLY_PHASE1":1401,"PHASE1":1403,"PHASE2":1405,"PHASE3":1407,"PHASE4":1409,"NA":1415},{"trials":1402,"activeCount":112},[],{"trials":1404,"activeCount":112},[],{"trials":1406,"activeCount":112},[],{"trials":1408,"activeCount":112},[],{"trials":1410,"activeCount":112},[1411],{"nctId":1347,"briefTitle":1348,"status":575,"phases":1412,"primaryCompletion":777,"completion":777,"start":1350,"enrollment":133,"conditions":1413,"interventions":1414},[89],[1352,1353,1354,1355,1356],[1334,1358,1359,1360],{"trials":1416,"activeCount":112},[],{"intervention":1418,"totalTrials":144,"cells":1419},"Medicinal honey",{"EARLY_PHASE1":1420,"PHASE1":1422,"PHASE2":1424,"PHASE3":1426,"PHASE4":1428,"NA":1440},{"trials":1421,"activeCount":112},[],{"trials":1423,"activeCount":112},[],{"trials":1425,"activeCount":112},[],{"trials":1427,"activeCount":112},[],{"trials":1429,"activeCount":112},[1430],{"nctId":1431,"briefTitle":1432,"status":99,"phases":1433,"primaryCompletion":1434,"completion":1434,"start":1435,"enrollment":9,"conditions":1436,"interventions":1438},"NCT03929224","The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown",[89],"2020-09-01","2018-10-25",[1437],"Skin Infection",[1418,1439],"Bacitracin",{"trials":1441,"activeCount":112},[],{"intervention":1439,"totalTrials":144,"cells":1443},{"EARLY_PHASE1":1444,"PHASE1":1446,"PHASE2":1448,"PHASE3":1450,"PHASE4":1452,"NA":1458},{"trials":1445,"activeCount":112},[],{"trials":1447,"activeCount":112},[],{"trials":1449,"activeCount":112},[],{"trials":1451,"activeCount":112},[],{"trials":1453,"activeCount":112},[1454],{"nctId":1431,"briefTitle":1432,"status":99,"phases":1455,"primaryCompletion":1434,"completion":1434,"start":1435,"enrollment":9,"conditions":1456,"interventions":1457},[89],[1437],[1418,1439],{"trials":1459,"activeCount":112},[],{"intervention":1461,"totalTrials":144,"cells":1462},"Cilostazol 100 MG",{"EARLY_PHASE1":1463,"PHASE1":1465,"PHASE2":1467,"PHASE3":1469,"PHASE4":1471,"NA":1484},{"trials":1464,"activeCount":112},[],{"trials":1466,"activeCount":112},[],{"trials":1468,"activeCount":112},[],{"trials":1470,"activeCount":112},[],{"trials":1472,"activeCount":112},[1473],{"nctId":1474,"briefTitle":1475,"status":575,"phases":1476,"primaryCompletion":1477,"completion":1478,"start":1479,"enrollment":1480,"conditions":1481,"interventions":1483},"NCT04148105","Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)",[89],"2023-05-21","2023-05-26","2019-11-01",19,[1482],"Aneurysmal Subarachnoid Hemorrhage",[1461],{"trials":1485,"activeCount":112},[],{"intervention":1487,"totalTrials":144,"cells":1488},"Suvorexant 10 mg",{"EARLY_PHASE1":1489,"PHASE1":1491,"PHASE2":1493,"PHASE3":1495,"PHASE4":1497,"NA":1507},{"trials":1490,"activeCount":112},[],{"trials":1492,"activeCount":112},[],{"trials":1494,"activeCount":112},[],{"trials":1496,"activeCount":112},[],{"trials":1498,"activeCount":112},[1499],{"nctId":1500,"briefTitle":1501,"status":99,"phases":1502,"primaryCompletion":1435,"completion":1435,"start":1503,"enrollment":16,"conditions":1504,"interventions":1505},"NCT03312517","Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs",[89],"2018-04-15",[15],[1487,1506],"Suvorexant 20 mg",{"trials":1508,"activeCount":112},[],{"intervention":1506,"totalTrials":144,"cells":1510},{"EARLY_PHASE1":1511,"PHASE1":1513,"PHASE2":1515,"PHASE3":1517,"PHASE4":1519,"NA":1525},{"trials":1512,"activeCount":112},[],{"trials":1514,"activeCount":112},[],{"trials":1516,"activeCount":112},[],{"trials":1518,"activeCount":112},[],{"trials":1520,"activeCount":112},[1521],{"nctId":1500,"briefTitle":1501,"status":99,"phases":1522,"primaryCompletion":1435,"completion":1435,"start":1503,"enrollment":16,"conditions":1523,"interventions":1524},[89],[15],[1487,1506],{"trials":1526,"activeCount":112},[],{"intervention":1528,"totalTrials":144,"cells":1529},"Gentamycin\u002Fcitrate, Minocycline\u002FEDTA",{"EARLY_PHASE1":1530,"PHASE1":1532,"PHASE2":1534,"PHASE3":1536,"PHASE4":1538,"NA":1550},{"trials":1531,"activeCount":112},[],{"trials":1533,"activeCount":112},[],{"trials":1535,"activeCount":112},[],{"trials":1537,"activeCount":112},[],{"trials":1539,"activeCount":112},[1540],{"nctId":1541,"briefTitle":1542,"status":99,"phases":1543,"completion":1544,"start":1545,"enrollment":1546,"conditions":1547,"interventions":1549},"NCT00294502","Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia",[89],"2004-05","2003-09",120,[1548],"ESRD",[1528],{"trials":1551,"activeCount":112},[],{"intervention":1553,"totalTrials":144,"cells":1554},"Continuous Infusion of ropivacaine",{"EARLY_PHASE1":1555,"PHASE1":1557,"PHASE2":1559,"PHASE3":1561,"PHASE4":1563,"NA":1575},{"trials":1556,"activeCount":112},[],{"trials":1558,"activeCount":112},[],{"trials":1560,"activeCount":112},[],{"trials":1562,"activeCount":112},[],{"trials":1564,"activeCount":112},[1565],{"nctId":1566,"briefTitle":1567,"status":99,"phases":1568,"primaryCompletion":1569,"completion":1569,"start":1570,"enrollment":1571,"conditions":1572,"interventions":1573},"NCT05642416","Intermittent Bolus vs Continuous Infusion Via ESP Catheters RCT",[89],"2024-12-23","2022-10-18",240,[281],[1553,1574],"Intermittent bolus of ropivacaine",{"trials":1576,"activeCount":112},[],{"intervention":1574,"totalTrials":144,"cells":1578},{"EARLY_PHASE1":1579,"PHASE1":1581,"PHASE2":1583,"PHASE3":1585,"PHASE4":1587,"NA":1593},{"trials":1580,"activeCount":112},[],{"trials":1582,"activeCount":112},[],{"trials":1584,"activeCount":112},[],{"trials":1586,"activeCount":112},[],{"trials":1588,"activeCount":112},[1589],{"nctId":1566,"briefTitle":1567,"status":99,"phases":1590,"primaryCompletion":1569,"completion":1569,"start":1570,"enrollment":1571,"conditions":1591,"interventions":1592},[89],[281],[1553,1574],{"trials":1594,"activeCount":112},[],{"intervention":1596,"totalTrials":144,"cells":1597},"Triamcinilone",{"EARLY_PHASE1":1598,"PHASE1":1600,"PHASE2":1602,"PHASE3":1604,"PHASE4":1606,"NA":1619},{"trials":1599,"activeCount":112},[],{"trials":1601,"activeCount":112},[],{"trials":1603,"activeCount":112},[],{"trials":1605,"activeCount":112},[],{"trials":1607,"activeCount":112},[1608],{"nctId":1609,"briefTitle":1610,"status":99,"phases":1611,"primaryCompletion":1612,"completion":1612,"start":1613,"enrollment":1614,"conditions":1615,"interventions":1618},"NCT00941473","Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women",[89],"2011-07","2007-07",28,[1616,1617],"To Assess the Changes in Markers of Bone Turnover Over a Six Month Period After Epidural Steroid Inject","To Assess the Changes in Bone Mineral Density",[1596],{"trials":1620,"activeCount":112},[],{"intervention":1622,"totalTrials":144,"cells":1623},"Gebauer's Pain Ease Top Aerosol Mist Spray",{"EARLY_PHASE1":1624,"PHASE1":1626,"PHASE2":1628,"PHASE3":1630,"PHASE4":1632,"NA":1646},{"trials":1625,"activeCount":112},[],{"trials":1627,"activeCount":112},[],{"trials":1629,"activeCount":112},[],{"trials":1631,"activeCount":112},[],{"trials":1633,"activeCount":112},[1634],{"nctId":1635,"briefTitle":1636,"status":99,"phases":1637,"primaryCompletion":1638,"completion":1638,"start":1639,"enrollment":1640,"conditions":1641,"interventions":1644},"NCT04207710","Safety of Gebauer's Pain Ease and Gebauer's Ethyl Chloride",[89],"2022-02-25","2021-01-26",72,[1642,18,1643],"Spray","Safety Issues",[1622,1645],"Gebauer's Ethyl Chloride",{"trials":1647,"activeCount":112},[],{"intervention":1645,"totalTrials":144,"cells":1649},{"EARLY_PHASE1":1650,"PHASE1":1652,"PHASE2":1654,"PHASE3":1656,"PHASE4":1658,"NA":1664},{"trials":1651,"activeCount":112},[],{"trials":1653,"activeCount":112},[],{"trials":1655,"activeCount":112},[],{"trials":1657,"activeCount":112},[],{"trials":1659,"activeCount":112},[1660],{"nctId":1635,"briefTitle":1636,"status":99,"phases":1661,"primaryCompletion":1638,"completion":1638,"start":1639,"enrollment":1640,"conditions":1662,"interventions":1663},[89],[1642,18,1643],[1622,1645],{"trials":1665,"activeCount":112},[],{"intervention":1667,"totalTrials":144,"cells":1668},"suvorexant",{"EARLY_PHASE1":1669,"PHASE1":1671,"PHASE2":1673,"PHASE3":1675,"PHASE4":1677,"NA":1688},{"trials":1670,"activeCount":112},[],{"trials":1672,"activeCount":112},[],{"trials":1674,"activeCount":112},[],{"trials":1676,"activeCount":112},[],{"trials":1678,"activeCount":112},[1679],{"nctId":1680,"briefTitle":1681,"status":575,"phases":1682,"primaryCompletion":1683,"completion":1683,"start":1684,"enrollment":842,"conditions":1685,"interventions":1687},"NCT02684136","Suvorexant in Insomnia Co-morbid With Fibromyalgia",[89],"2018-07-01","2016-02-01",[15,1686],"Fibromyalgia",[1667],{"trials":1689,"activeCount":112},[],{"intervention":1691,"totalTrials":144,"cells":1692},"Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks",{"EARLY_PHASE1":1693,"PHASE1":1695,"PHASE2":1697,"PHASE3":1699,"PHASE4":1701,"NA":1713},{"trials":1694,"activeCount":112},[],{"trials":1696,"activeCount":112},[],{"trials":1698,"activeCount":112},[],{"trials":1700,"activeCount":112},[],{"trials":1702,"activeCount":112},[1703],{"nctId":1704,"briefTitle":1705,"status":575,"phases":1706,"primaryCompletion":1707,"completion":1707,"start":1708,"enrollment":994,"conditions":1709,"interventions":1712},"NCT00310765","Pregabalin for Abdominal Pain From Adhesions",[89],"2008-08","2006-03",[1710,1711],"Abdominal Pain","Surgical Adhesions",[1691],{"trials":1714,"activeCount":112},[],{"intervention":1160,"totalTrials":144,"cells":1716},{"EARLY_PHASE1":1717,"PHASE1":1719,"PHASE2":1721,"PHASE3":1723,"PHASE4":1725,"NA":1731},{"trials":1718,"activeCount":112},[],{"trials":1720,"activeCount":112},[],{"trials":1722,"activeCount":112},[],{"trials":1724,"activeCount":112},[],{"trials":1726,"activeCount":112},[1727],{"nctId":1148,"briefTitle":1149,"status":99,"phases":1728,"primaryCompletion":1151,"completion":1151,"start":1113,"enrollment":1152,"conditions":1729,"interventions":1730},[89],[1154,1155,1156,1157,1158],[1160,1105],{"trials":1732,"activeCount":112},[],{"intervention":1734,"totalTrials":144,"cells":1735},"arformoterol",{"EARLY_PHASE1":1736,"PHASE1":1738,"PHASE2":1740,"PHASE3":1742,"PHASE4":1744,"NA":1756},{"trials":1737,"activeCount":112},[],{"trials":1739,"activeCount":112},[],{"trials":1741,"activeCount":112},[],{"trials":1743,"activeCount":112},[],{"trials":1745,"activeCount":112},[1746],{"nctId":1747,"briefTitle":1748,"status":575,"phases":1749,"primaryCompletion":1750,"completion":1750,"start":1751,"enrollment":188,"conditions":1752,"interventions":1754},"NCT00819637","A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients",[89],"2009-11","2009-01",[1753],"Acute Asthma",[1734,1755],"levalbuterol",{"trials":1757,"activeCount":112},[],{"intervention":1755,"totalTrials":144,"cells":1759},{"EARLY_PHASE1":1760,"PHASE1":1762,"PHASE2":1764,"PHASE3":1766,"PHASE4":1768,"NA":1774},{"trials":1761,"activeCount":112},[],{"trials":1763,"activeCount":112},[],{"trials":1765,"activeCount":112},[],{"trials":1767,"activeCount":112},[],{"trials":1769,"activeCount":112},[1770],{"nctId":1747,"briefTitle":1748,"status":575,"phases":1771,"primaryCompletion":1750,"completion":1750,"start":1751,"enrollment":188,"conditions":1772,"interventions":1773},[89],[1753],[1734,1755],{"trials":1775,"activeCount":112},[],{"intervention":1777,"totalTrials":144,"cells":1778},"Zolpidem CR",{"EARLY_PHASE1":1779,"PHASE1":1781,"PHASE2":1783,"PHASE3":1785,"PHASE4":1787,"NA":1800},{"trials":1780,"activeCount":112},[],{"trials":1782,"activeCount":112},[],{"trials":1784,"activeCount":112},[],{"trials":1786,"activeCount":112},[],{"trials":1788,"activeCount":112},[1789],{"nctId":1790,"briefTitle":1791,"status":99,"phases":1792,"primaryCompletion":1793,"completion":1793,"start":1794,"enrollment":1795,"conditions":1796,"interventions":1798},"NCT02456532","Safety and Efficacy of Chronic Hypnotic Use 2",[89],"2022-02-22","2015-08-05",41,[1797],"Chronic Insomnia",[1777,1799],"Eszopiclone",{"trials":1801,"activeCount":112},[],{"intervention":1799,"totalTrials":144,"cells":1803},{"EARLY_PHASE1":1804,"PHASE1":1806,"PHASE2":1808,"PHASE3":1810,"PHASE4":1812,"NA":1818},{"trials":1805,"activeCount":112},[],{"trials":1807,"activeCount":112},[],{"trials":1809,"activeCount":112},[],{"trials":1811,"activeCount":112},[],{"trials":1813,"activeCount":112},[1814],{"nctId":1790,"briefTitle":1791,"status":99,"phases":1815,"primaryCompletion":1793,"completion":1793,"start":1794,"enrollment":1795,"conditions":1816,"interventions":1817},[89],[1797],[1777,1799],{"trials":1819,"activeCount":112},[],{"intervention":1821,"totalTrials":144,"cells":1822},"Exparel",{"EARLY_PHASE1":1823,"PHASE1":1825,"PHASE2":1827,"PHASE3":1829,"PHASE4":1831,"NA":1841},{"trials":1824,"activeCount":112},[],{"trials":1826,"activeCount":112},[],{"trials":1828,"activeCount":112},[],{"trials":1830,"activeCount":112},[],{"trials":1832,"activeCount":112},[1833],{"nctId":1834,"briefTitle":1835,"status":276,"phases":1836,"primaryCompletion":1837,"completion":1837,"start":1185,"enrollment":112,"conditions":1838,"interventions":1839},"NCT02542956","Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management",[89],"2018-12",[18],[1821,1840,1840],"Marcaine",{"trials":1842,"activeCount":112},[],{"intervention":1840,"totalTrials":144,"cells":1844},{"EARLY_PHASE1":1845,"PHASE1":1847,"PHASE2":1849,"PHASE3":1851,"PHASE4":1853,"NA":1859},{"trials":1846,"activeCount":112},[],{"trials":1848,"activeCount":112},[],{"trials":1850,"activeCount":112},[],{"trials":1852,"activeCount":112},[],{"trials":1854,"activeCount":112},[1855],{"nctId":1834,"briefTitle":1835,"status":276,"phases":1856,"primaryCompletion":1837,"completion":1837,"start":1185,"enrollment":112,"conditions":1857,"interventions":1858},[89],[18],[1821,1840,1840],{"trials":1860,"activeCount":112},[],{"intervention":1862,"totalTrials":144,"cells":1863},"Epidural analgesia",{"EARLY_PHASE1":1864,"PHASE1":1866,"PHASE2":1868,"PHASE3":1870,"PHASE4":1872,"NA":1885},{"trials":1865,"activeCount":112},[],{"trials":1867,"activeCount":112},[],{"trials":1869,"activeCount":112},[],{"trials":1871,"activeCount":112},[],{"trials":1873,"activeCount":112},[1874],{"nctId":1875,"briefTitle":1876,"status":276,"phases":1877,"primaryCompletion":1878,"completion":1878,"start":1879,"enrollment":112,"conditions":1880,"interventions":1884},"NCT04888858","Effect of Epidural Analgesia During Labor on Force of Maternal Push",[89],"2022-07-02","2020-11-02",[1881,1882,1883],"Labor Pain","Analgesia","Maternal; Procedure",[1862],{"trials":1886,"activeCount":112},[],{"intervention":1888,"totalTrials":144,"cells":1889},"Sugammadex",{"EARLY_PHASE1":1890,"PHASE1":1892,"PHASE2":1894,"PHASE3":1896,"PHASE4":1898,"NA":1910},{"trials":1891,"activeCount":112},[],{"trials":1893,"activeCount":112},[],{"trials":1895,"activeCount":112},[],{"trials":1897,"activeCount":112},[],{"trials":1899,"activeCount":112},[1900],{"nctId":1901,"briefTitle":1902,"status":276,"phases":1903,"primaryCompletion":1904,"completion":1904,"start":1905,"enrollment":112,"conditions":1906,"interventions":1908},"NCT03574337","Residual Neuromuscular Blockade in Cardiac Surgery Patients",[89],"2018-08-30","2018-08-01",[1907],"Residual Neuromuscular Blockade",[1888,1909],"neostigmine\u002Fglycopyrolate",{"trials":1911,"activeCount":112},[],{"intervention":1909,"totalTrials":144,"cells":1913},{"EARLY_PHASE1":1914,"PHASE1":1916,"PHASE2":1918,"PHASE3":1920,"PHASE4":1922,"NA":1928},{"trials":1915,"activeCount":112},[],{"trials":1917,"activeCount":112},[],{"trials":1919,"activeCount":112},[],{"trials":1921,"activeCount":112},[],{"trials":1923,"activeCount":112},[1924],{"nctId":1901,"briefTitle":1902,"status":276,"phases":1925,"primaryCompletion":1904,"completion":1904,"start":1905,"enrollment":112,"conditions":1926,"interventions":1927},[89],[1907],[1888,1909],{"trials":1929,"activeCount":112},[],{"intervention":1931,"totalTrials":144,"cells":1932},"lubiprostone",{"EARLY_PHASE1":1933,"PHASE1":1935,"PHASE2":1937,"PHASE3":1939,"PHASE4":1941,"NA":1952},{"trials":1934,"activeCount":112},[],{"trials":1936,"activeCount":112},[],{"trials":1938,"activeCount":112},[],{"trials":1940,"activeCount":112},[],{"trials":1942,"activeCount":112},[1943],{"nctId":1944,"briefTitle":1945,"status":99,"phases":1946,"primaryCompletion":1612,"completion":1612,"start":1947,"enrollment":1948,"conditions":1949,"interventions":1951},"NCT00645801","Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation",[89],"2008-03",158,[1950],"Colonoscopy",[1931],{"trials":1953,"activeCount":112},[],{"intervention":1955,"totalTrials":144,"cells":1956},"Bevacizumab",{"EARLY_PHASE1":1957,"PHASE1":1959,"PHASE2":1961,"PHASE3":1963,"PHASE4":1975,"NA":1977},{"trials":1958,"activeCount":112},[],{"trials":1960,"activeCount":112},[],{"trials":1962,"activeCount":112},[],{"trials":1964,"activeCount":112},[1965],{"nctId":1966,"briefTitle":1967,"status":99,"phases":1968,"primaryCompletion":1113,"completion":1113,"start":1969,"enrollment":1970,"conditions":1971,"interventions":1973},"NCT05718466","Stereotactic Radiology Versus Chemotherapy for Recurrent\u002FProgressive Glioblastoma After Second-Line Chemotherapy",[88],"2010-11",35,[1972],"Recurrent or Progressive Glioblastoma",[1955,1974],"Chemotherapy",{"trials":1976,"activeCount":112},[],{"trials":1978,"activeCount":112},[],{"intervention":1974,"totalTrials":144,"cells":1980},{"EARLY_PHASE1":1981,"PHASE1":1983,"PHASE2":1985,"PHASE3":1987,"PHASE4":1993,"NA":1995},{"trials":1982,"activeCount":112},[],{"trials":1984,"activeCount":112},[],{"trials":1986,"activeCount":112},[],{"trials":1988,"activeCount":112},[1989],{"nctId":1966,"briefTitle":1967,"status":99,"phases":1990,"primaryCompletion":1113,"completion":1113,"start":1969,"enrollment":1970,"conditions":1991,"interventions":1992},[88],[1972],[1955,1974],{"trials":1994,"activeCount":112},[],{"trials":1996,"activeCount":112},[],{"intervention":1998,"totalTrials":144,"cells":1999},"Hydroxychloroquine - Daily Dosing",{"EARLY_PHASE1":2000,"PHASE1":2002,"PHASE2":2004,"PHASE3":2006,"PHASE4":2022,"NA":2024},{"trials":2001,"activeCount":112},[],{"trials":2003,"activeCount":112},[],{"trials":2005,"activeCount":112},[],{"trials":2007,"activeCount":112},[2008],{"nctId":2009,"briefTitle":2010,"status":575,"phases":2011,"primaryCompletion":2012,"completion":2012,"start":2013,"enrollment":2014,"conditions":2015,"interventions":2020},"NCT04341441","Will Hydroxychloroquine Impede or Prevent COVID-19",[88],"2020-12-15","2020-04-07",624,[2016,2017,2018,2019],"COVID-19","Coronavirus","Coronavirus Infections","SARS-CoV 2",[1998,2021],"Hydroxychloroquine - Weekly Dosing",{"trials":2023,"activeCount":112},[],{"trials":2025,"activeCount":112},[],{"intervention":2021,"totalTrials":144,"cells":2027},{"EARLY_PHASE1":2028,"PHASE1":2030,"PHASE2":2032,"PHASE3":2034,"PHASE4":2040,"NA":2042},{"trials":2029,"activeCount":112},[],{"trials":2031,"activeCount":112},[],{"trials":2033,"activeCount":112},[],{"trials":2035,"activeCount":112},[2036],{"nctId":2009,"briefTitle":2010,"status":575,"phases":2037,"primaryCompletion":2012,"completion":2012,"start":2013,"enrollment":2014,"conditions":2038,"interventions":2039},[88],[2016,2017,2018,2019],[1998,2021],{"trials":2041,"activeCount":112},[],{"trials":2043,"activeCount":112},[],{"intervention":2045,"totalTrials":144,"cells":2046},"Tranexamic Acid Pill",{"EARLY_PHASE1":2047,"PHASE1":2049,"PHASE2":2051,"PHASE3":2053,"PHASE4":2066,"NA":2068},{"trials":2048,"activeCount":112},[],{"trials":2050,"activeCount":112},[],{"trials":2052,"activeCount":112},[],{"trials":2054,"activeCount":112},[2055],{"nctId":2056,"briefTitle":2057,"status":276,"phases":2058,"primaryCompletion":2059,"completion":2060,"start":2061,"enrollment":112,"conditions":2062,"interventions":2065},"NCT05518279","Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures",[88],"2021-08","2021-09","2019-09",[2063,2064],"Hip Fractures","Blood Loss",[2045],{"trials":2067,"activeCount":112},[],{"trials":2069,"activeCount":112},[],{"intervention":2071,"totalTrials":144,"cells":2072},"Erlotinib",{"EARLY_PHASE1":2073,"PHASE1":2075,"PHASE2":2077,"PHASE3":2079,"PHASE4":2091,"NA":2093},{"trials":2074,"activeCount":112},[],{"trials":2076,"activeCount":112},[],{"trials":2078,"activeCount":112},[],{"trials":2080,"activeCount":112},[2081],{"nctId":2082,"briefTitle":2083,"status":575,"phases":2084,"primaryCompletion":2085,"completion":2085,"start":2086,"enrollment":28,"conditions":2087,"interventions":2090},"NCT00448240","Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer",[87,88],"2012-01","2007-02",[2088,2089],"Head and Neck Cancer","Carcinoma, Squamous Cell",[2071],{"trials":2092,"activeCount":112},[],{"trials":2094,"activeCount":112},[],{"intervention":2096,"totalTrials":144,"cells":2097},"Botulinum Toxins",{"EARLY_PHASE1":2098,"PHASE1":2100,"PHASE2":2102,"PHASE3":2104,"PHASE4":2116,"NA":2118},{"trials":2099,"activeCount":112},[],{"trials":2101,"activeCount":112},[],{"trials":2103,"activeCount":112},[],{"trials":2105,"activeCount":112},[2106],{"nctId":2107,"briefTitle":2108,"status":99,"phases":2109,"primaryCompletion":2110,"completion":2110,"start":2111,"enrollment":2112,"conditions":2113,"interventions":2115},"NCT03887377","The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation",[87,88],"2024-12-30","2019-06-10",22,[695,696,2114],"Mammary Disorder",[2096],{"trials":2117,"activeCount":112},[],{"trials":2119,"activeCount":112},[],{"intervention":2121,"totalTrials":144,"cells":2122},"dexamethasone to injury site",{"EARLY_PHASE1":2123,"PHASE1":2125,"PHASE2":2127,"PHASE3":2129,"PHASE4":2141,"NA":2143},{"trials":2124,"activeCount":112},[],{"trials":2126,"activeCount":112},[],{"trials":2128,"activeCount":112},[],{"trials":2130,"activeCount":112},[2131],{"nctId":2132,"briefTitle":2133,"status":99,"phases":2134,"completion":2135,"start":2136,"enrollment":2137,"conditions":2138,"interventions":2140},"NCT00257634","Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis",[88],"2007-01","2004-12",80,[346,2139],"Work Related Injury",[2121],{"trials":2142,"activeCount":112},[],{"trials":2144,"activeCount":112},[],{"intervention":2146,"totalTrials":188,"cells":2147},"Ad5-yCD\u002FmutTKSR39rep-ADP",{"EARLY_PHASE1":2148,"PHASE1":2150,"PHASE2":2161,"PHASE3":2173,"PHASE4":2175,"NA":2177},{"trials":2149,"activeCount":112},[],{"trials":2151,"activeCount":112},[2152],{"nctId":2153,"briefTitle":2154,"status":575,"phases":2155,"start":2156,"enrollment":2157,"conditions":2158,"interventions":2160},"NCT00415454","Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma",[86],"2006-11",8,[2159],"Pancreatic Cancer",[2146],{"trials":2162,"activeCount":112},[2163],{"nctId":2164,"briefTitle":2165,"status":99,"phases":2166,"primaryCompletion":2167,"completion":2167,"start":2168,"enrollment":2169,"conditions":2170,"interventions":2172},"NCT00583492","Randomized Trial of Suicide Gene Therapy and Prostate Cancer",[87],"2013-09","2007-12",44,[2171],"Prostate Cancer",[2146],{"trials":2174,"activeCount":112},[],{"trials":2176,"activeCount":112},[],{"trials":2178,"activeCount":112},[],{"intervention":2180,"totalTrials":144,"cells":2181},"Droxidopa",{"EARLY_PHASE1":2182,"PHASE1":2184,"PHASE2":2186,"PHASE3":2201,"PHASE4":2203,"NA":2205},{"trials":2183,"activeCount":112},[],{"trials":2185,"activeCount":112},[],{"trials":2187,"activeCount":112},[2188],{"nctId":2189,"briefTitle":2190,"status":150,"phases":2191,"primaryCompletion":2192,"completion":2193,"start":2194,"enrollment":950,"conditions":2195,"interventions":2199},"NCT02066571","Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease",[87],"2017-04","2017-12","2015-03",[2196,2197,2198],"Parkinson's Disease","Freezing of Gait","Cognitive Ability, General",[2180,2200],"sugar pill",{"trials":2202,"activeCount":112},[],{"trials":2204,"activeCount":112},[],{"trials":2206,"activeCount":112},[],{"intervention":2200,"totalTrials":144,"cells":2208},{"EARLY_PHASE1":2209,"PHASE1":2211,"PHASE2":2213,"PHASE3":2219,"PHASE4":2221,"NA":2223},{"trials":2210,"activeCount":112},[],{"trials":2212,"activeCount":112},[],{"trials":2214,"activeCount":112},[2215],{"nctId":2189,"briefTitle":2190,"status":150,"phases":2216,"primaryCompletion":2192,"completion":2193,"start":2194,"enrollment":950,"conditions":2217,"interventions":2218},[87],[2196,2197,2198],[2180,2200],{"trials":2220,"activeCount":112},[],{"trials":2222,"activeCount":112},[],{"trials":2224,"activeCount":112},[],{"intervention":2226,"totalTrials":144,"cells":2227},"Convalescent plasma",{"EARLY_PHASE1":2228,"PHASE1":2230,"PHASE2":2232,"PHASE3":2245,"PHASE4":2247,"NA":2249},{"trials":2229,"activeCount":112},[],{"trials":2231,"activeCount":112},[],{"trials":2233,"activeCount":112},[2234],{"nctId":2235,"briefTitle":2236,"status":99,"phases":2237,"primaryCompletion":2238,"completion":2238,"start":2239,"enrollment":2240,"conditions":2241,"interventions":2244},"NCT04385199","Convalescent Plasma for Patients With COVID-19",[87],"2020-08-01","2020-05-04",30,[2242,2017,2243],"Coronavirus Infection","COVID",[2226],{"trials":2246,"activeCount":112},[],{"trials":2248,"activeCount":112},[],{"trials":2250,"activeCount":112},[],{"intervention":2252,"totalTrials":144,"cells":2253},"clevidipine",{"EARLY_PHASE1":2254,"PHASE1":2256,"PHASE2":2258,"PHASE3":2272,"PHASE4":2274,"NA":2276},{"trials":2255,"activeCount":112},[],{"trials":2257,"activeCount":112},[],{"trials":2259,"activeCount":112},[2260],{"nctId":2261,"briefTitle":2262,"status":276,"phases":2263,"primaryCompletion":2264,"completion":2265,"start":2266,"enrollment":112,"conditions":2267,"interventions":2271},"NCT02011321","Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)",[87],"2018-03","2018-09","2014-03",[2268,2269,2270],"Subarachnoid Hemorrhage","Cerebral Aneurysm","Vasospasm, Intracranial",[2252],{"trials":2273,"activeCount":112},[],{"trials":2275,"activeCount":112},[],{"trials":2277,"activeCount":112},[],{"intervention":2279,"totalTrials":144,"cells":2280},"Capsaicin 0.1% Cream",{"EARLY_PHASE1":2281,"PHASE1":2283,"PHASE2":2285,"PHASE3":2297,"PHASE4":2299,"NA":2301},{"trials":2282,"activeCount":112},[],{"trials":2284,"activeCount":112},[],{"trials":2286,"activeCount":112},[2287],{"nctId":2288,"briefTitle":2289,"status":99,"phases":2290,"primaryCompletion":2291,"completion":2291,"start":2292,"enrollment":2240,"conditions":2293,"interventions":2295},"NCT03223350","Topical Capsaicin for Cyclical Vomiting",[87],"2019-08-05","2017-12-20",[2294],"Cyclical Vomiting",[2279,2296],"Placebos",{"trials":2298,"activeCount":112},[],{"trials":2300,"activeCount":112},[],{"trials":2302,"activeCount":112},[],{"intervention":2296,"totalTrials":144,"cells":2304},{"EARLY_PHASE1":2305,"PHASE1":2307,"PHASE2":2309,"PHASE3":2315,"PHASE4":2317,"NA":2319},{"trials":2306,"activeCount":112},[],{"trials":2308,"activeCount":112},[],{"trials":2310,"activeCount":112},[2311],{"nctId":2288,"briefTitle":2289,"status":99,"phases":2312,"primaryCompletion":2291,"completion":2291,"start":2292,"enrollment":2240,"conditions":2313,"interventions":2314},[87],[2294],[2279,2296],{"trials":2316,"activeCount":112},[],{"trials":2318,"activeCount":112},[],{"trials":2320,"activeCount":112},[],{"intervention":2322,"totalTrials":144,"cells":2323},"Methylprednisolone 40 MG",{"EARLY_PHASE1":2324,"PHASE1":2326,"PHASE2":2328,"PHASE3":2338,"PHASE4":2340,"NA":2342},{"trials":2325,"activeCount":112},[],{"trials":2327,"activeCount":112},[],{"trials":2329,"activeCount":112},[2330],{"nctId":2331,"briefTitle":2332,"status":276,"phases":2333,"primaryCompletion":2334,"completion":2334,"start":2335,"enrollment":112,"conditions":2336,"interventions":2337},"NCT06163755","Comparison of Efficacy of Intra-articular Morphine vs Methylprednisolone in Patients With Knee Osteoarthritis.",[87],"2018-12-31","2018-01-01",[781],[2322],{"trials":2339,"activeCount":112},[],{"trials":2341,"activeCount":112},[],{"trials":2343,"activeCount":112},[],{"intervention":2345,"totalTrials":144,"cells":2346},"Clevidipine butyrate injectable emulsion",{"EARLY_PHASE1":2347,"PHASE1":2349,"PHASE2":2351,"PHASE3":2362,"PHASE4":2364,"NA":2366},{"trials":2348,"activeCount":112},[],{"trials":2350,"activeCount":112},[],{"trials":2352,"activeCount":112},[2353],{"nctId":2354,"briefTitle":2355,"status":575,"phases":2356,"primaryCompletion":2357,"completion":2358,"start":2359,"enrollment":192,"conditions":2360,"interventions":2361},"NCT00978822","Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage",[87],"2012-11","2012-12","2009-06",[2268,1102],[2345],{"trials":2363,"activeCount":112},[],{"trials":2365,"activeCount":112},[],{"trials":2367,"activeCount":112},[],{"intervention":2369,"totalTrials":144,"cells":2370},"Levofloxacin",{"EARLY_PHASE1":2371,"PHASE1":2373,"PHASE2":2375,"PHASE3":2389,"PHASE4":2391,"NA":2393},{"trials":2372,"activeCount":112},[],{"trials":2374,"activeCount":112},[],{"trials":2376,"activeCount":112},[2377],{"nctId":2378,"briefTitle":2379,"status":99,"phases":2380,"primaryCompletion":2381,"completion":2381,"start":2382,"enrollment":2383,"conditions":2384,"interventions":2387},"NCT03850379","Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant",[87],"2024-08-30","2018-03-14",308,[2385,2386],"Prophylaxis","Stem Cell Transplant Complications",[2369,2388],"Ciprofloxacin",{"trials":2390,"activeCount":112},[],{"trials":2392,"activeCount":112},[],{"trials":2394,"activeCount":112},[],{"intervention":2388,"totalTrials":144,"cells":2396},{"EARLY_PHASE1":2397,"PHASE1":2399,"PHASE2":2401,"PHASE3":2407,"PHASE4":2409,"NA":2411},{"trials":2398,"activeCount":112},[],{"trials":2400,"activeCount":112},[],{"trials":2402,"activeCount":112},[2403],{"nctId":2378,"briefTitle":2379,"status":99,"phases":2404,"primaryCompletion":2381,"completion":2381,"start":2382,"enrollment":2383,"conditions":2405,"interventions":2406},[87],[2385,2386],[2369,2388],{"trials":2408,"activeCount":112},[],{"trials":2410,"activeCount":112},[],{"trials":2412,"activeCount":112},[],{"intervention":2414,"totalTrials":144,"cells":2415},"Folfox6",{"EARLY_PHASE1":2416,"PHASE1":2418,"PHASE2":2420,"PHASE3":2434,"PHASE4":2436,"NA":2438},{"trials":2417,"activeCount":112},[],{"trials":2419,"activeCount":112},[],{"trials":2421,"activeCount":112},[2422],{"nctId":2423,"briefTitle":2424,"status":99,"phases":2425,"primaryCompletion":2426,"completion":2427,"start":2428,"enrollment":2429,"conditions":2430,"interventions":2432},"NCT02243358","Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer",[87],"2017-06-28","2020-01-14","2014-02",24,[2431],"Pancreas Neoplasm Malignant Resectable",[2414,2433],"Gemcitabine",{"trials":2435,"activeCount":112},[],{"trials":2437,"activeCount":112},[],{"trials":2439,"activeCount":112},[],{"intervention":2433,"totalTrials":144,"cells":2441},{"EARLY_PHASE1":2442,"PHASE1":2444,"PHASE2":2446,"PHASE3":2452,"PHASE4":2454,"NA":2456},{"trials":2443,"activeCount":112},[],{"trials":2445,"activeCount":112},[],{"trials":2447,"activeCount":112},[2448],{"nctId":2423,"briefTitle":2424,"status":99,"phases":2449,"primaryCompletion":2426,"completion":2427,"start":2428,"enrollment":2429,"conditions":2450,"interventions":2451},[87],[2431],[2414,2433],{"trials":2453,"activeCount":112},[],{"trials":2455,"activeCount":112},[],{"trials":2457,"activeCount":112},[],{"intervention":2459,"totalTrials":144,"cells":2460},"Extended-Release Niacin",{"EARLY_PHASE1":2461,"PHASE1":2463,"PHASE2":2465,"PHASE3":2475,"PHASE4":2477,"NA":2479},{"trials":2462,"activeCount":112},[],{"trials":2464,"activeCount":112},[],{"trials":2466,"activeCount":112},[2467],{"nctId":2468,"briefTitle":2469,"status":99,"phases":2470,"primaryCompletion":2471,"completion":2471,"start":2472,"enrollment":1614,"conditions":2473,"interventions":2474},"NCT00796887","Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery",[87],"2012-08","2009-04",[30],[2459,2459],{"trials":2476,"activeCount":112},[],{"trials":2478,"activeCount":112},[],{"trials":2480,"activeCount":112},[],{"intervention":2482,"totalTrials":144,"cells":2483},"Acamprosate",{"EARLY_PHASE1":2484,"PHASE1":2486,"PHASE2":2488,"PHASE3":2500,"PHASE4":2502,"NA":2504},{"trials":2485,"activeCount":112},[],{"trials":2487,"activeCount":112},[],{"trials":2489,"activeCount":112},[2490],{"nctId":2491,"briefTitle":2492,"status":276,"phases":2493,"primaryCompletion":2494,"completion":2193,"start":2495,"enrollment":112,"conditions":2496,"interventions":2498},"NCT06312800","Acamprosate and Methazolamide for Essential Tremor",[87],"2017-06","2016-03",[2497],"Essential Tremor",[2482,2499],"Methazolamide",{"trials":2501,"activeCount":112},[],{"trials":2503,"activeCount":112},[],{"trials":2505,"activeCount":112},[],{"intervention":2499,"totalTrials":144,"cells":2507},{"EARLY_PHASE1":2508,"PHASE1":2510,"PHASE2":2512,"PHASE3":2518,"PHASE4":2520,"NA":2522},{"trials":2509,"activeCount":112},[],{"trials":2511,"activeCount":112},[],{"trials":2513,"activeCount":112},[2514],{"nctId":2491,"briefTitle":2492,"status":276,"phases":2515,"primaryCompletion":2494,"completion":2193,"start":2495,"enrollment":112,"conditions":2516,"interventions":2517},[87],[2497],[2482,2499],{"trials":2519,"activeCount":112},[],{"trials":2521,"activeCount":112},[],{"trials":2523,"activeCount":112},[],{"intervention":2525,"totalTrials":144,"cells":2526},"Citalopram",{"EARLY_PHASE1":2527,"PHASE1":2529,"PHASE2":2531,"PHASE3":2542,"PHASE4":2544,"NA":2546},{"trials":2528,"activeCount":112},[],{"trials":2530,"activeCount":112},[],{"trials":2532,"activeCount":112},[2533],{"nctId":2534,"briefTitle":2535,"status":276,"phases":2536,"primaryCompletion":1684,"completion":2537,"start":2538,"enrollment":112,"conditions":2539,"interventions":2541},"NCT01667744","Citalopram for Sx\u002FUtil in Acute Coronary Syndrome Patients",[86,87],"2021-02-16","2016-01-01",[2540],"Acute Coronary Syndrome",[2525],{"trials":2543,"activeCount":112},[],{"trials":2545,"activeCount":112},[],{"trials":2547,"activeCount":112},[],{"intervention":2549,"totalTrials":188,"cells":2550},"Ad5-yCD\u002FmutTKSR39rep-hIL12",{"EARLY_PHASE1":2551,"PHASE1":2553,"PHASE2":2572,"PHASE3":2574,"PHASE4":2576,"NA":2578},{"trials":2552,"activeCount":112},[],{"trials":2554,"activeCount":112},[2555,2564],{"nctId":2556,"briefTitle":2557,"status":99,"phases":2558,"primaryCompletion":2559,"completion":2559,"start":2560,"enrollment":16,"conditions":2561,"interventions":2563},"NCT03281382","Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer",[86],"2019-05-28","2017-07-01",[2562],"Metastatic Pancreatic Cancer",[2549],{"nctId":2565,"briefTitle":2566,"status":99,"phases":2567,"primaryCompletion":2568,"completion":2569,"start":578,"enrollment":816,"conditions":2570,"interventions":2571},"NCT02555397","Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer",[86],"2019-06-16","2024-01-22",[2171],[2549],{"trials":2573,"activeCount":112},[],{"trials":2575,"activeCount":112},[],{"trials":2577,"activeCount":112},[],{"trials":2579,"activeCount":112},[],{"intervention":2581,"totalTrials":144,"cells":2582},"Sildenafil",{"EARLY_PHASE1":2583,"PHASE1":2585,"PHASE2":2594,"PHASE3":2596,"PHASE4":2598,"NA":2600},{"trials":2584,"activeCount":112},[],{"trials":2586,"activeCount":112},[2587],{"nctId":2588,"briefTitle":2589,"status":575,"phases":2590,"start":2591,"enrollment":950,"conditions":2592,"interventions":2593},"NCT00452582","Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke",[86],"2005-04",[30],[2581],{"trials":2595,"activeCount":112},[],{"trials":2597,"activeCount":112},[],{"trials":2599,"activeCount":112},[],{"trials":2601,"activeCount":112},[],{"intervention":2603,"totalTrials":144,"cells":2604},"SARS-CoV-2 plasma",{"EARLY_PHASE1":2605,"PHASE1":2607,"PHASE2":2617,"PHASE3":2619,"PHASE4":2621,"NA":2623},{"trials":2606,"activeCount":112},[],{"trials":2608,"activeCount":112},[2609],{"nctId":2610,"briefTitle":2611,"status":276,"phases":2612,"primaryCompletion":2613,"completion":2613,"start":2013,"enrollment":112,"conditions":2614,"interventions":2616},"NCT04411602","Intermediate IND Severe Illness COVID-19 CP",[86],"2021-04-07",[2615,2243],"Severe Acute Respiratory Syndrome",[2603],{"trials":2618,"activeCount":112},[],{"trials":2620,"activeCount":112},[],{"trials":2622,"activeCount":112},[],{"trials":2624,"activeCount":112},[],{"intervention":2626,"totalTrials":144,"cells":2627},"Poly-L Lactic Acid",{"EARLY_PHASE1":2628,"PHASE1":2639,"PHASE2":2641,"PHASE3":2643,"PHASE4":2645,"NA":2647},{"trials":2629,"activeCount":112},[2630],{"nctId":2631,"briefTitle":2632,"status":99,"phases":2633,"primaryCompletion":2634,"completion":2634,"start":2635,"enrollment":842,"conditions":2636,"interventions":2638},"NCT03858543","Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae",[85],"2021-01-31","2019-07-15",[2637],"Striae Distensae",[2626],{"trials":2640,"activeCount":112},[],{"trials":2642,"activeCount":112},[],{"trials":2644,"activeCount":112},[],{"trials":2646,"activeCount":112},[],{"trials":2648,"activeCount":112},[],{"intervention":2650,"totalTrials":144,"cells":2651},"Pembrolizumab 25 MG\u002F1 ML Intravenous Solution [KEYTRUDA]",{"EARLY_PHASE1":2652,"PHASE1":2664,"PHASE2":2666,"PHASE3":2668,"PHASE4":2670,"NA":2672},{"trials":2653,"activeCount":112},[2654],{"nctId":2655,"briefTitle":2656,"status":99,"phases":2657,"primaryCompletion":2658,"completion":2659,"start":2660,"enrollment":842,"conditions":2661,"interventions":2663},"NCT04188951","HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer",[85],"2023-06-15","2024-05-08","2019-10-04",[2662],"Head and Neck Neoplasms",[2650],{"trials":2665,"activeCount":112},[],{"trials":2667,"activeCount":112},[],{"trials":2669,"activeCount":112},[],{"trials":2671,"activeCount":112},[],{"trials":2673,"activeCount":112},[],{"intervention":108,"totalTrials":144,"cells":2675},{"EARLY_PHASE1":2676,"PHASE1":2682,"PHASE2":2684,"PHASE3":2686,"PHASE4":2688,"NA":2690},{"trials":2677,"activeCount":112},[2678],{"nctId":97,"briefTitle":98,"status":99,"phases":2679,"primaryCompletion":101,"completion":102,"start":103,"enrollment":8,"conditions":2680,"interventions":2681},[85],[105,106],[39,108,63,109,110,111],{"trials":2683,"activeCount":112},[],{"trials":2685,"activeCount":112},[],{"trials":2687,"activeCount":112},[],{"trials":2689,"activeCount":112},[],{"trials":2691,"activeCount":112},[],{"intervention":2693,"totalTrials":144,"cells":2694},"zolpidem",{"EARLY_PHASE1":2695,"PHASE1":2697,"PHASE2":2699,"PHASE3":2701,"PHASE4":2703,"NA":2705},{"trials":2696,"activeCount":112},[],{"trials":2698,"activeCount":112},[],{"trials":2700,"activeCount":112},[],{"trials":2702,"activeCount":112},[],{"trials":2704,"activeCount":112},[],{"trials":2706,"activeCount":112},[2707],{"nctId":2708,"briefTitle":2709,"status":99,"phases":2710,"primaryCompletion":2711,"completion":2711,"start":2712,"enrollment":2713,"conditions":2714,"interventions":2716},"NCT01006525","Safety and Efficacy of Chronic Hypnotic Use",[],"2011-08","2005-12",116,[2715],"Primary Insomnia",[2693],{"intervention":2718,"totalTrials":144,"cells":2719},"Polypodium Leucotomos",{"EARLY_PHASE1":2720,"PHASE1":2722,"PHASE2":2724,"PHASE3":2726,"PHASE4":2728,"NA":2730},{"trials":2721,"activeCount":112},[],{"trials":2723,"activeCount":112},[],{"trials":2725,"activeCount":112},[],{"trials":2727,"activeCount":112},[],{"trials":2729,"activeCount":112},[],{"trials":2731,"activeCount":112},[2732],{"nctId":2733,"briefTitle":2734,"status":99,"phases":2735,"primaryCompletion":2736,"completion":2737,"start":2738,"enrollment":2112,"conditions":2739,"interventions":2741},"NCT02904798","The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos",[90],"2017-02-14","2017-04-23","2015-07-01",[2740],"Photodermatoses",[2718],{"intervention":2743,"totalTrials":144,"cells":2744},"Oxytocin",{"EARLY_PHASE1":2745,"PHASE1":2747,"PHASE2":2749,"PHASE3":2751,"PHASE4":2753,"NA":2755},{"trials":2746,"activeCount":112},[],{"trials":2748,"activeCount":112},[],{"trials":2750,"activeCount":112},[],{"trials":2752,"activeCount":112},[],{"trials":2754,"activeCount":112},[],{"trials":2756,"activeCount":112},[2757],{"nctId":2758,"briefTitle":2759,"status":99,"phases":2760,"primaryCompletion":2761,"completion":2761,"start":2738,"enrollment":2762,"conditions":2763,"interventions":2765},"NCT02465164","Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin",[90],"2016-07-30",26,[2764],"Cervical Ripening",[2743],{"intervention":2767,"totalTrials":144,"cells":2768},"Curcumin-phosphatidylcholine",{"EARLY_PHASE1":2769,"PHASE1":2771,"PHASE2":2773,"PHASE3":2775,"PHASE4":2777,"NA":2779},{"trials":2770,"activeCount":112},[],{"trials":2772,"activeCount":112},[],{"trials":2774,"activeCount":112},[],{"trials":2776,"activeCount":112},[],{"trials":2778,"activeCount":112},[],{"trials":2780,"activeCount":112},[2781],{"nctId":2782,"briefTitle":2783,"status":150,"phases":2784,"primaryCompletion":153,"completion":153,"start":2785,"enrollment":738,"conditions":2786,"interventions":2788},"NCT04800107","Effect of Highly Bioavailable Curcumin on Subjective Tinnitus",[90],"2021-01-06",[2787],"Tinnitus, Subjective",[2767],{"intervention":2790,"totalTrials":144,"cells":2791},"Interleukin 28B genotype",{"EARLY_PHASE1":2792,"PHASE1":2794,"PHASE2":2796,"PHASE3":2798,"PHASE4":2800,"NA":2802},{"trials":2793,"activeCount":112},[],{"trials":2795,"activeCount":112},[],{"trials":2797,"activeCount":112},[],{"trials":2799,"activeCount":112},[],{"trials":2801,"activeCount":112},[],{"trials":2803,"activeCount":112},[2804],{"nctId":2805,"briefTitle":2806,"status":99,"phases":2807,"primaryCompletion":2808,"completion":2809,"start":2711,"enrollment":2810,"conditions":2811,"interventions":2813},"NCT01429155","Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B",[],"2013-01","2013-03",36,[2812],"Hepatitis C",[2790],{"intervention":2815,"totalTrials":144,"cells":2816},"Midazolam",{"EARLY_PHASE1":2817,"PHASE1":2819,"PHASE2":2821,"PHASE3":2823,"PHASE4":2825,"NA":2827},{"trials":2818,"activeCount":112},[],{"trials":2820,"activeCount":112},[],{"trials":2822,"activeCount":112},[],{"trials":2824,"activeCount":112},[],{"trials":2826,"activeCount":112},[],{"trials":2828,"activeCount":112},[2829],{"nctId":2830,"briefTitle":2831,"status":99,"phases":2832,"primaryCompletion":2833,"completion":2834,"start":2835,"enrollment":2836,"conditions":2837,"interventions":2840},"NCT04453449","The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks",[],"2021-09-01","2021-10-15","2020-06-25",95,[2838,2839],"Lumbar Spine Spondylosis","Anxiety Generalized",[2815],{"intervention":2842,"totalTrials":144,"cells":2843},"Antibiotics",{"EARLY_PHASE1":2844,"PHASE1":2846,"PHASE2":2848,"PHASE3":2850,"PHASE4":2852,"NA":2854},{"trials":2845,"activeCount":112},[],{"trials":2847,"activeCount":112},[],{"trials":2849,"activeCount":112},[],{"trials":2851,"activeCount":112},[],{"trials":2853,"activeCount":112},[],{"trials":2855,"activeCount":112},[2856],{"nctId":2857,"briefTitle":2858,"status":99,"phases":2859,"primaryCompletion":1183,"completion":1183,"start":2860,"enrollment":2861,"conditions":2862,"interventions":2864},"NCT03046082","Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit",[],"2016-01",192,[2863],"Pneumonia",[2842],{"intervention":2866,"totalTrials":144,"cells":2867},"beclomethasone dipropionate",{"EARLY_PHASE1":2868,"PHASE1":2870,"PHASE2":2872,"PHASE3":2874,"PHASE4":2876,"NA":2878},{"trials":2869,"activeCount":112},[],{"trials":2871,"activeCount":112},[],{"trials":2873,"activeCount":112},[],{"trials":2875,"activeCount":112},[],{"trials":2877,"activeCount":112},[],{"trials":2879,"activeCount":112},[2880],{"nctId":2881,"briefTitle":2882,"status":99,"phases":2883,"primaryCompletion":2884,"completion":2885,"start":2886,"enrollment":2887,"conditions":2888,"interventions":2889},"NCT01142947","Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)",[90],"2017-02","2019-03-11","2007-10",362,[27],[2866],{"intervention":2891,"totalTrials":144,"cells":2892},"Clopidogrel",{"EARLY_PHASE1":2893,"PHASE1":2895,"PHASE2":2897,"PHASE3":2899,"PHASE4":2901,"NA":2903},{"trials":2894,"activeCount":112},[],{"trials":2896,"activeCount":112},[],{"trials":2898,"activeCount":112},[],{"trials":2900,"activeCount":112},[],{"trials":2902,"activeCount":112},[],{"trials":2904,"activeCount":112},[2905],{"nctId":2906,"briefTitle":2907,"status":575,"phases":2908,"primaryCompletion":2909,"completion":2909,"start":2910,"enrollment":816,"conditions":2911,"interventions":2913},"NCT02499666","Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI",[],"2017-10-30","2015-06-29",[21,2912],"Angina Pectoris",[2891],{"intervention":2915,"totalTrials":144,"cells":2916},"Marcaine 0.25 % Injectable Solution",{"EARLY_PHASE1":2917,"PHASE1":2919,"PHASE2":2921,"PHASE3":2923,"PHASE4":2925,"NA":2927},{"trials":2918,"activeCount":112},[],{"trials":2920,"activeCount":112},[],{"trials":2922,"activeCount":112},[],{"trials":2924,"activeCount":112},[],{"trials":2926,"activeCount":112},[],{"trials":2928,"activeCount":112},[2929],{"nctId":2930,"briefTitle":2931,"status":99,"phases":2932,"primaryCompletion":1132,"completion":2933,"start":1183,"enrollment":320,"conditions":2934,"interventions":2935},"NCT03033589","Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength",[90],"2017-12-31",[18],[2915,2915],{"intervention":2937,"totalTrials":144,"cells":2938},"Bakuchiol",{"EARLY_PHASE1":2939,"PHASE1":2941,"PHASE2":2943,"PHASE3":2945,"PHASE4":2947,"NA":2949},{"trials":2940,"activeCount":112},[],{"trials":2942,"activeCount":112},[],{"trials":2944,"activeCount":112},[],{"trials":2946,"activeCount":112},[],{"trials":2948,"activeCount":112},[],{"trials":2950,"activeCount":112},[2951],{"nctId":2952,"briefTitle":2953,"status":99,"phases":2954,"primaryCompletion":2955,"completion":2956,"start":2957,"enrollment":2112,"conditions":2958,"interventions":2960},"NCT06833996","The Efficacy of Bakuchiol in Treating PIH",[90],"2018-05-23","2019-05-05","2016-02-22",[2959],"Post Inflammatory Hyperpigmentation",[2937,2961],"Vehicle",{"intervention":2961,"totalTrials":144,"cells":2963},{"EARLY_PHASE1":2964,"PHASE1":2966,"PHASE2":2968,"PHASE3":2970,"PHASE4":2972,"NA":2974},{"trials":2965,"activeCount":112},[],{"trials":2967,"activeCount":112},[],{"trials":2969,"activeCount":112},[],{"trials":2971,"activeCount":112},[],{"trials":2973,"activeCount":112},[],{"trials":2975,"activeCount":112},[2976],{"nctId":2952,"briefTitle":2953,"status":99,"phases":2977,"primaryCompletion":2955,"completion":2956,"start":2957,"enrollment":2112,"conditions":2978,"interventions":2979},[90],[2959],[2937,2961],{"intervention":2981,"totalTrials":144,"cells":2982},"Metformin",{"EARLY_PHASE1":2983,"PHASE1":2985,"PHASE2":2987,"PHASE3":2989,"PHASE4":2991,"NA":2993},{"trials":2984,"activeCount":112},[],{"trials":2986,"activeCount":112},[],{"trials":2988,"activeCount":112},[],{"trials":2990,"activeCount":112},[],{"trials":2992,"activeCount":112},[],{"trials":2994,"activeCount":112},[2995],{"nctId":2996,"briefTitle":2997,"status":99,"phases":2998,"primaryCompletion":2999,"completion":2999,"start":3000,"enrollment":1300,"conditions":3001,"interventions":3005},"NCT01125150","Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia",[],"2012-06","2009-02",[3002,3003,3004],"Acanthosis Nigricans","Hyperinsulinemia","Spectroscopic Analysis",[2981],{"intervention":3007,"totalTrials":144,"cells":3008},"Magnesium Sulfate",{"EARLY_PHASE1":3009,"PHASE1":3011,"PHASE2":3013,"PHASE3":3015,"PHASE4":3017,"NA":3019},{"trials":3010,"activeCount":112},[],{"trials":3012,"activeCount":112},[],{"trials":3014,"activeCount":112},[],{"trials":3016,"activeCount":112},[],{"trials":3018,"activeCount":112},[],{"trials":3020,"activeCount":112},[3021],{"nctId":3022,"briefTitle":3023,"status":99,"phases":3024,"primaryCompletion":1183,"completion":1183,"start":2860,"enrollment":3025,"conditions":3026,"interventions":3028},"NCT03617289","Efficacy of Magnesium Sulfate on Reducing Renal Colic in the Emergency Department",[90],37,[3027],"Renal Colic",[3007,3029],"D5W",{"intervention":3029,"totalTrials":144,"cells":3031},{"EARLY_PHASE1":3032,"PHASE1":3034,"PHASE2":3036,"PHASE3":3038,"PHASE4":3040,"NA":3042},{"trials":3033,"activeCount":112},[],{"trials":3035,"activeCount":112},[],{"trials":3037,"activeCount":112},[],{"trials":3039,"activeCount":112},[],{"trials":3041,"activeCount":112},[],{"trials":3043,"activeCount":112},[3044],{"nctId":3022,"briefTitle":3023,"status":99,"phases":3045,"primaryCompletion":1183,"completion":1183,"start":2860,"enrollment":3025,"conditions":3046,"interventions":3047},[90],[3027],[3007,3029],{"intervention":3049,"totalTrials":144,"cells":3050},"Tricholoacetic Acid",{"EARLY_PHASE1":3051,"PHASE1":3053,"PHASE2":3055,"PHASE3":3057,"PHASE4":3059,"NA":3061},{"trials":3052,"activeCount":112},[],{"trials":3054,"activeCount":112},[],{"trials":3056,"activeCount":112},[],{"trials":3058,"activeCount":112},[],{"trials":3060,"activeCount":112},[],{"trials":3062,"activeCount":112},[3063],{"nctId":3064,"briefTitle":3065,"status":99,"phases":3066,"primaryCompletion":3067,"completion":3068,"start":3069,"enrollment":2240,"conditions":3070,"interventions":3072},"NCT02905903","An In Vivo Model for Postinflammatory Hyperpigmentation",[90],"2018-05-16","2019-06-21","2016-02-14",[3071],"Post-inflammatory Hyperpigmentation",[3049],{"intervention":3074,"totalTrials":144,"cells":3075},"Clindamycin & Rifampin",{"EARLY_PHASE1":3076,"PHASE1":3078,"PHASE2":3080,"PHASE3":3082,"PHASE4":3084,"NA":3086},{"trials":3077,"activeCount":112},[],{"trials":3079,"activeCount":112},[],{"trials":3081,"activeCount":112},[],{"trials":3083,"activeCount":112},[],{"trials":3085,"activeCount":112},[],{"trials":3087,"activeCount":112},[3088],{"nctId":3089,"briefTitle":3090,"status":99,"phases":3091,"primaryCompletion":1612,"completion":3092,"start":3093,"enrollment":994,"conditions":3094,"interventions":3095},"NCT01063270","Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa",[90],"2013-12","2010-02",[23],[3074],{"intervention":3097,"totalTrials":144,"cells":3098},"botulinum type a",{"EARLY_PHASE1":3099,"PHASE1":3101,"PHASE2":3103,"PHASE3":3105,"PHASE4":3107,"NA":3109},{"trials":3100,"activeCount":112},[],{"trials":3102,"activeCount":112},[],{"trials":3104,"activeCount":112},[],{"trials":3106,"activeCount":112},[],{"trials":3108,"activeCount":112},[],{"trials":3110,"activeCount":112},[3111],{"nctId":3112,"briefTitle":3113,"status":99,"phases":3114,"primaryCompletion":3115,"completion":3115,"start":2135,"enrollment":3116,"conditions":3117,"interventions":3118},"NCT00628472","Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort",[90],"2007-05",21,[18],[3097],{"intervention":3120,"totalTrials":144,"cells":3121},"Ertapenem",{"EARLY_PHASE1":3122,"PHASE1":3124,"PHASE2":3126,"PHASE3":3128,"PHASE4":3130,"NA":3132},{"trials":3123,"activeCount":112},[],{"trials":3125,"activeCount":112},[],{"trials":3127,"activeCount":112},[],{"trials":3129,"activeCount":112},[],{"trials":3131,"activeCount":112},[],{"trials":3133,"activeCount":112},[3134],{"nctId":3135,"briefTitle":3136,"status":276,"phases":3137,"primaryCompletion":3138,"completion":3139,"start":3140,"enrollment":112,"conditions":3141,"interventions":3142},"NCT05255575","A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa",[],"2019-07-07","2019-08-07","2018-03-01",[23],[3120],{"intervention":3144,"totalTrials":144,"cells":3145},"PEG-ELS current standard of care",{"EARLY_PHASE1":3146,"PHASE1":3148,"PHASE2":3150,"PHASE3":3152,"PHASE4":3154,"NA":3156},{"trials":3147,"activeCount":112},[],{"trials":3149,"activeCount":112},[],{"trials":3151,"activeCount":112},[],{"trials":3153,"activeCount":112},[],{"trials":3155,"activeCount":112},[],{"trials":3157,"activeCount":112},[3158],{"nctId":3159,"briefTitle":3160,"status":276,"phases":3161,"primaryCompletion":3162,"completion":3162,"start":3163,"enrollment":112,"conditions":3164,"interventions":3166},"NCT04361656","The Effect of Adding Lubiprostone to Standard Large-Volume PEG-ELS on The Quality of Inpatient Colonoscopy Preparation",[],"2021-02-04","2020-05-01",[3165],"Colonoscopy Preparation",[3144,3167],"PEG-ELS current standard of care plus Lubiprostone 24 microgram Oral Cap",{"intervention":3167,"totalTrials":144,"cells":3169},{"EARLY_PHASE1":3170,"PHASE1":3172,"PHASE2":3174,"PHASE3":3176,"PHASE4":3178,"NA":3180},{"trials":3171,"activeCount":112},[],{"trials":3173,"activeCount":112},[],{"trials":3175,"activeCount":112},[],{"trials":3177,"activeCount":112},[],{"trials":3179,"activeCount":112},[],{"trials":3181,"activeCount":112},[3182],{"nctId":3159,"briefTitle":3160,"status":276,"phases":3183,"primaryCompletion":3162,"completion":3162,"start":3163,"enrollment":112,"conditions":3184,"interventions":3185},[],[3165],[3144,3167],{"intervention":3187,"totalTrials":144,"cells":3188},"Indigocyanine green dye",{"EARLY_PHASE1":3189,"PHASE1":3191,"PHASE2":3193,"PHASE3":3195,"PHASE4":3197,"NA":3199},{"trials":3190,"activeCount":112},[],{"trials":3192,"activeCount":112},[],{"trials":3194,"activeCount":112},[],{"trials":3196,"activeCount":112},[],{"trials":3198,"activeCount":112},[],{"trials":3200,"activeCount":112},[3201],{"nctId":3202,"briefTitle":3203,"status":276,"phases":3204,"primaryCompletion":3205,"completion":3205,"start":3206,"enrollment":112,"conditions":3207,"interventions":3209},"NCT01610739","Carpal Tunnel Release Effects on Median Nerve Perfusion",[90],"2013-06","2012-07",[3208],"Carpal Tunnel Syndrome",[3187],{"intervention":3211,"totalTrials":144,"cells":3212},"Methylprednisolone",{"EARLY_PHASE1":3213,"PHASE1":3215,"PHASE2":3217,"PHASE3":3219,"PHASE4":3221,"NA":3223},{"trials":3214,"activeCount":112},[],{"trials":3216,"activeCount":112},[],{"trials":3218,"activeCount":112},[],{"trials":3220,"activeCount":112},[],{"trials":3222,"activeCount":112},[],{"trials":3224,"activeCount":112},[3225],{"nctId":3226,"briefTitle":3227,"status":99,"phases":3228,"primaryCompletion":3229,"completion":3230,"start":3231,"enrollment":3232,"conditions":3233,"interventions":3235},"NCT04374071","Early Short Course Corticosteroids in COVID-19",[],"2020-03-27","2020-04-30","2020-03-12",250,[2243,3234],"Pneumonia, Viral",[3211],{"intervention":3237,"totalTrials":144,"cells":3238},"Chitosan succinamide",{"EARLY_PHASE1":3239,"PHASE1":3241,"PHASE2":3243,"PHASE3":3245,"PHASE4":3247,"NA":3249},{"trials":3240,"activeCount":112},[],{"trials":3242,"activeCount":112},[],{"trials":3244,"activeCount":112},[],{"trials":3246,"activeCount":112},[],{"trials":3248,"activeCount":112},[],{"trials":3250,"activeCount":112},[3251],{"nctId":3252,"briefTitle":3253,"status":276,"phases":3254,"primaryCompletion":3255,"completion":3255,"start":3256,"enrollment":112,"conditions":3257,"interventions":3259},"NCT04783233","Chitogel CSK-4 Gel as Packing in Tympanoplasty Surgery",[],"2021-11-03","2021-01-14",[3258],"Tympanoplasty Surgery",[3237,3260],"Gelfoam",{"intervention":3260,"totalTrials":144,"cells":3262},{"EARLY_PHASE1":3263,"PHASE1":3265,"PHASE2":3267,"PHASE3":3269,"PHASE4":3271,"NA":3273},{"trials":3264,"activeCount":112},[],{"trials":3266,"activeCount":112},[],{"trials":3268,"activeCount":112},[],{"trials":3270,"activeCount":112},[],{"trials":3272,"activeCount":112},[],{"trials":3274,"activeCount":112},[3275],{"nctId":3252,"briefTitle":3253,"status":276,"phases":3276,"primaryCompletion":3255,"completion":3255,"start":3256,"enrollment":112,"conditions":3277,"interventions":3278},[],[3258],[3237,3260],{"intervention":3280,"totalTrials":144,"cells":3281},"Topical corticosteroid alone",{"EARLY_PHASE1":3282,"PHASE1":3284,"PHASE2":3286,"PHASE3":3288,"PHASE4":3290,"NA":3292},{"trials":3283,"activeCount":112},[],{"trials":3285,"activeCount":112},[],{"trials":3287,"activeCount":112},[],{"trials":3289,"activeCount":112},[],{"trials":3291,"activeCount":112},[],{"trials":3293,"activeCount":112},[3294],{"nctId":3295,"briefTitle":3296,"status":150,"phases":3297,"primaryCompletion":3298,"completion":3092,"start":3299,"enrollment":950,"conditions":3300,"interventions":3314},"NCT00757315","NdYag Laser for Acne Keloidalis Nuchae",[90],"2009-09","2008-09",[3301,3302,3303,3304,3305,3306,3307,3308,3309,3310,3311,3312,3313],"Acne Keloidalis Nuchae","NdYag Laser","AKN","Acne Keloidalis","AK","Dermatitis Papillaris Capillitii","Folliculitis Keloidalis Nuchae","Sycosis Nuchae","Acne Keloid","Keloidal Folliculitis","Lichen Keloidalis Nuchae","Folliculitis Nuchae Scleroticans","Sycosis Framboesiformis",[3280],{"intervention":3316,"totalTrials":144,"cells":3317},"10% Benzoyl Peroxide Topical Body Wash",{"EARLY_PHASE1":3318,"PHASE1":3320,"PHASE2":3322,"PHASE3":3324,"PHASE4":3326,"NA":3328},{"trials":3319,"activeCount":112},[],{"trials":3321,"activeCount":112},[],{"trials":3323,"activeCount":112},[],{"trials":3325,"activeCount":112},[],{"trials":3327,"activeCount":112},[],{"trials":3329,"activeCount":112},[3330],{"nctId":3331,"briefTitle":3332,"status":99,"phases":3333,"primaryCompletion":3334,"completion":3335,"start":3336,"enrollment":3337,"conditions":3338,"interventions":3339},"NCT01818167","An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.",[90],"2014-12-31","2015-01-21","2013-01-05",25,[23],[3316,3340],"Provodine Topical Cream",{"intervention":3340,"totalTrials":144,"cells":3342},{"EARLY_PHASE1":3343,"PHASE1":3345,"PHASE2":3347,"PHASE3":3349,"PHASE4":3351,"NA":3353},{"trials":3344,"activeCount":112},[],{"trials":3346,"activeCount":112},[],{"trials":3348,"activeCount":112},[],{"trials":3350,"activeCount":112},[],{"trials":3352,"activeCount":112},[],{"trials":3354,"activeCount":112},[3355],{"nctId":3331,"briefTitle":3332,"status":99,"phases":3356,"primaryCompletion":3334,"completion":3335,"start":3336,"enrollment":3337,"conditions":3357,"interventions":3358},[90],[23],[3316,3340],{"intervention":3360,"totalTrials":144,"cells":3361},"Pentoxifylline",{"EARLY_PHASE1":3362,"PHASE1":3364,"PHASE2":3366,"PHASE3":3368,"PHASE4":3370,"NA":3372},{"trials":3363,"activeCount":112},[],{"trials":3365,"activeCount":112},[],{"trials":3367,"activeCount":112},[],{"trials":3369,"activeCount":112},[],{"trials":3371,"activeCount":112},[],{"trials":3373,"activeCount":112},[3374],{"nctId":3375,"briefTitle":3376,"status":276,"phases":3377,"primaryCompletion":2809,"completion":2809,"start":3378,"enrollment":112,"conditions":3379,"interventions":3381},"NCT01337349","Effects of Pentoxiphylline on Left Ventricular (LV) Systolic Function Indices and Circulating Biomarkers in Patients With Chronic Congestive Heart Failure (CHF)",[90],"2010-07",[3380],"Congestive Heart Failure",[3360],{"intervention":3383,"totalTrials":144,"cells":3384},"Botulinum Toxin A",{"EARLY_PHASE1":3385,"PHASE1":3387,"PHASE2":3389,"PHASE3":3391,"PHASE4":3393,"NA":3395},{"trials":3386,"activeCount":112},[],{"trials":3388,"activeCount":112},[],{"trials":3390,"activeCount":112},[],{"trials":3392,"activeCount":112},[],{"trials":3394,"activeCount":112},[],{"trials":3396,"activeCount":112},[3397],{"nctId":3398,"briefTitle":3399,"status":99,"phases":3400,"primaryCompletion":3401,"completion":3401,"start":3402,"enrollment":19,"conditions":3403,"interventions":3406},"NCT01056861","Effects of Botulinum Toxin in Cervical Dystonia",[],"2014-07","2010-01",[3404,3405],"Torticollis","Cervical Dystonia",[3383]]